Roche’s Women as Visionaries in Eyecare (#wave) initiative connects women in ophthalmology whose work, experience and ambition are helping shape eyecare. If you’re at #euretina2026, join us at the Roche booth for inspiring talks and to connect with a community working to move the field forward.
#euretina26
Roche
F. Hoffmann-La Roche AG, commonly known as Roche (), is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. More on Wikipedia
-
Roche
@Roche
-
Roche
@Roche
At Roche our commitment to #breastcancer research has been guided by science and a dedication to improving outcomes for people living with cancer. 🧵👇
Post not available here, view on X
Roche
@Roche
We continue to focus our scientific efforts on areas of high unmet need, aiming to translate research insights into meaningful health solutions.
Roche
@Roche
HR-positive #breastcancer is the most common subtype, but early-stage recurrence and progression following initial therapies remain a reality for many.
Together, we’re working to help change this. -
Roche
@Roche
To move retinal care forward, we must understand how solutions perform in everyday practice.
As @EURETINA 2026 continues, Nilesh Mehta, Therapeutic Area Head, Ophthalmology at Roche, is sharing what our latest real-world evidence could mean for patients with neovascular age-related macular degeneration (#namd) and diabetic macular edema (#dme).
#euretina26 -
Roche
@Roche
#media – We are pleased that the New England Journal of Medicine has published phase III data demonstrating significant progression-free survival benefit with our investigational medicine for people with ER-positive advanced #breastcancer.
Read more here👉www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
Expanding the possible starts with fresh ideas, emerging leaders and new perspectives. The Leading Edge Incubator (LEI) is designed to empower the next generation shaping the future of ophthalmology.
Attending #euretina26? Stop by the Roche booth to meet current LEI members and learn about innovations from the 2025-26 cohort.
#euretina2026 -
Roche
@Roche
#media – At #euretina2026, we’re pleased to share new real-world data confirming effectiveness and safety across major retinal conditions, including nAMD, DME and RVO.
-
Roche
@Roche
#media – We are pleased that the U.S. FDA has accepted the new drug application for our investigational medicine for both relapsing and primary progressive multiple sclerosis.
Read here 👉 www.roche.com/media
#multiplesclerosis #ms -
Roche
@Roche
Weak circulating tumor DNA (ctDNA) signals remain a primary bottleneck in minimal residual disease research. Roche’s sequencing by expansion (SBX) achieves the throughput necessary to bypass standard resolution limits. Discover more: go.roche.com/xsbxgen2
(Research use only)
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
Better cancer outcomes shouldn't demand bigger budgets—they demand smarter innovation.
Reflecting on this year's World Cancer Congress, the path forward is clear: the real cost of cancer isn’t just treatment, but the time stolen from families when care comes too late.
By prioritising earlier diagnosis and care closer to home, we don't just free up hospital capacity. We change the equation entirely—turning progress into healthy years of life.
#whatsitworth #wcc2026 #globalhealth -
Roche
@Roche
Breast cancer care shouldn't depend on where you live.
At this year's World Cancer Congress, the message was clear: regional collaboration is key to ensuring every woman gets the care she deserves, no matter where she lives.
By working across borders to bring diagnosis and treatment closer to home, we can turn progress into time—time for women to keep pursuing their dreams.
#whatsitworth #wcc2026 #globalhealth -
Roche
@Roche
#media – We are excited to share positive interim phase III results in IgA nephropathy, a progressive kidney disease that can lead to kidney failure.
Read more here 👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
We are pleased to share positive topline Phase II results from our investigational dual GLP-1/GIP receptor agonist in people living with type 2 diabetes, obesity or overweight. Read more here: www.roche.com/media/releases $ROG $RHHBY #obesity
-
Roche
@Roche
#media - We are pleased to share that the European Commission (EC) has approved our continuous delivery treatment for adults with neovascular age-related macular degeneration (#namd), offering an alternative to standard-of-care eye injections. www.roche.com/media
-
Roche
@Roche
#media –The CHMP has recommended approval of our multiple sclerosis treatment for young people aged 10+ living with relapsing MS in the EU, who have limited options today.
👉www.roche.com/media/releases/med-cor-2026-09-18
#multiplesclerosis #ms -
Roche
@Roche
#media – We are pleased to announce that the phase III study met its primary endpoint, significantly improving progression-free survival for people with second-line or later relapsed or refractory #follicularlymphoma #hematology www.roche.com/media $ROG $RHHBY
-
Roche
@Roche
Finding faint molecular clues early is critical for cancer research. Sequencing by expansion (SBX) technology can help researchers detect traces of circulating tumor DNA (ctDNA) to help reveal how tumors grow, change and react to treatment.
Learn how: go.roche.com/xgensbx
(Research use only)
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
#media – We’re pleased to share positive Phase III data from our collaborator MediLink’s study in Chinese patients with relapsed small-cell #lungcancer, being presented at #wclc26. Read more here: www.roche.com/media/releases $ROG $RHHBY
-
Roche
@Roche
#media – At #apvrs2026, we're pleased to share new two-year data for our treatment in patients with PCV, a severe sub-type of nAMD – the leading cause of vision loss in people over 60. www.roche.com/media
-
Roche
@Roche
Sleep should be a time of rest, not a time of risk.
"I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to us."
Discover how AI-enabled predictive algorithm turns data into actionable insights for navigating everyday life: www.roche.com/stories/diabetes-management
#diabetescare #digitalhealth #nightlowpredict #innovation #roche -
Roche
@Roche
#media – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#namd) - the leading cause of blindness in people over 60. 👉 www.roche.com/media
-
Roche
@Roche
Roche continues strong momentum with 6% sales growth (CER) in the first half of 2026 – full-year outlook confirmed.
For more details on our performance, click here ➡️ www.roche.com/media/releases/med-cor-2026-07-23Post not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #biotech #innovation
go.roche.com/xnanosbx
(Roche's sequencing technology is currently for research use only.) -
Roche
@Roche
#media – We are pleased to announce that the U.S. FDA has accepted Roche’s supplemental Biologics License Application, with priority review, in primary
#membranousnephropathy
Read more here 👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. www.roche.com/media
$RHHBY $ROG
Available in countries accepting the CE mark. For in vitro diagnostic use. Please consult the Instructions for Use for complete product information, including intended use and limitations. -
Roche
@Roche
Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer to global TB elimination. 🌍
www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
#media – We are pleased to share that Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at #aaic26. Learn more 👉 www.roche.com/media
-
Roche
@Roche
#media We are pleased to share that our Phase III study in advanced #kras G12C-positive #nsclc met its primary endpoint, demonstrating positive top-line results. Read more here: www.roche.com/media/releases
-
Roche
@Roche
The Bundibugyo virus is a rare and deadly strain of #ebola that often escapes detection by commonly used frontline tests. That’s why containing outbreaks while providing critical surveillance to monitor any further spread is vital. Our commitment to reinforcing healthcare infrastructure remains absolute, ensuring communities are better equipped to minimize the burden of infectious diseases.
#innovation #pandemicpreparedness -
Roche
@Roche
#media - We are pleased that the US FDA has accepted the supplemental Biologics License Application (sBLA) for our investigational medicine for thyroid eye disease (TED).
👉 www.roche.com/media -
Roche
@Roche
#media - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research
workflows, demonstrating end‑to‑end whole‑genome results within hours. www.roche.com/media/releases
#genomics #humangenetics #rochesbx #innovation #ngs
$ROG $RHHBY -
Roche
@Roche
As the @EHA_Hematology Congress (#eha2026) kicks off, hear from Steve Tuplin, Haematology Franchise Head at Roche, on our commitment to exploring combination approaches that advance B-cell malignancy outcomes. 👇
-
Roche
@Roche
#media – We are pleased that the US FDA has accepted the New Drug Application for our investigational medicine in ER-positive early-stage #breastcancer in the adjuvant setting www.roche.com/media/releases $ROG $RHHBY
-
Roche
@Roche
Mass spectrometry is transforming diagnostics, but simply having the tech isn't enough. The real breakthrough comes from seamlessly integrating it into the lab's entire workflow. Hear from Roche’s Benjamin Lilienfield about the value of integration to healthcare labs.
go.roche.com/bjms
#rochemassspec -
Roche
@Roche
#media - Chronic liver disease causes more than two million deaths worldwide every year, despite 90% of cases being preventable. To help address this, Roche is launching a comprehensive Liver Disease Panel, featuring certified algorithms to improve early detection. roche.com/media/releases
#digitalhealth #earlydetection #cld -
Roche
@Roche
Big News from the World Health Assembly! 🌍 Roche and the @MedsPatentPool sign voluntary license agreement to expand global access to innovative antiviral medicine in low-and-middle income countries and strengthen global health resilience against influenza 🏥
For more information, visit: medicinespatentpool.org/news-publications/news-and-press-…
#globalhealth #accesstomedicines #healthsecurity #globalhealthsecurity #pandemicpreparedness #voluntarylicensing #wha79 -
Roche
@Roche
In critical care, every second counts. And now scientists can generate answers – in record time.
Hear about how sequencing by expansion (SBX) technology is evolving genomics: www.youtube.com/watch?v=O2IANAoPO5g
(The SBX technology is in development and not commercially available. The content of this material reflects current study results and/or design goals.)
#genomics #humangenetics #rochesbx #innovation #ngs -
Roche
@Roche
Alzheimer's changes can start decades before symptoms, a critical window for intervention. Roche is tackling this with blood technologies for earlier detection, helping individuals plan care and slow disease progression. go.roche.com/xptauorg
#innovation #healthcare #technology #alzheimers #neuroscience -
Roche
@Roche
#media - New data show the Elecsys pTau217 blood test achieves accuracy comparable to PET for detecting Alzheimer's amyloid pathology, enabling scalable testing from a simple blood draw in routine care settings. www.roche.com/media/releases
#healthcare #alzheimers #neuroscience
$ROG $RHHBY -
Roche
@Roche
This #worldlupusday, we’re raising awareness of the real-world impact of lupus, and the realities people face everyday.
Around 3.4 million people worldwide are living with #systemiclupuserythematosus (SLE).
Up to 1 in 3 adults with SLE have #lupusnephritis at diagnosis, and up to 50% may develop it within five years.
Lupus can affect multiple organs, including the kidneys, and it can take 2-6 years to receive an accurate diagnosis - during which time disease flares may lead to irreversible organ damage and reduced quality of life. Click here to learn more about SLE and lupus nephritis!
#lupusawarenessmonth #livingwithlupus #systemiclupuserythematosus #sle #lupusnephritis -
Roche
@Roche
How could sequencing by expansion (SBX) technology could shape cancer research? Find out more: www.youtube.com/watch?v=CYvbm1TdV1I
(The SBX technology is in development and not commercially available. The content of this material reflects current study results and/or design goals.)
#genomics #humangenetics #rochesbx #innovation #ngs -
Roche
@Roche
#media - At #arvo2026, we’re pleased to share promising data showing progress in preserving vision and managing complex retinal conditions. www.roche.com/media
-
Roche
@Roche
We’re proud to announce our continued collaboration with the @wfhemophilia, through their Humanitarian Aid Program, working together to expand access to care for people with #haemophilia in locations where there is little to no access to treatment.
Read more via their website: wfh.org/article/roche-renews-commitment-to-wfh-humanitari…
#bleedingdisorders #publichealth #wfhcongress2026 -
Roche
@Roche
Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc. For more details, click here ➡️ www.roche.com/media/releases/med-cor-2026-04-23
$ROG $RHHBY #financialresults -
Roche
@Roche
#media - We’re pleased to share detailed, late-breaking results at #aanam from two positive Phase III studies of our investigational oral, brain-penetrant medicine in relapsing multiple sclerosis. www.roche.com/media
$RHHBY $ROP -
Roche
@Roche
#media - At #aanam , we’re pleased to share new positive Phase III data in myelin oligodendrocyte glycoprotein antibody-associated disease (#mogad), a disease for which there are no approved treatments. www.roche.com/media
$RHHBY $ROP -
Roche
@Roche
#media – We are pleased to announce that the US FDA has accepted Roche’s New Drug Application in #systemiclupuserythematos.
This important step moves us closer to providing a first-of-its-kind targeted treatment for people whose lives are significantly impacted by this debilitating autoimmune disease.
www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
Sequencing by expansion (SBX) is being designed to transform next-gen sequencing (NGS). Scientists will choose the best tool for their needs, adjust read lengths on one system, and handle small or large batches with ease.
Discover how SBX is poised to revolutionize disease research.
go.roche.com/xsbxflx
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
Diagnostics are the "intelligence" of health security. Roche is proud to join the Global One Health Diagnostics Access Compact to help expand access to reliable testing and build a more resilient tomorrow. Together, we can make the shift towards proactive care.
#onehealth #amr -
Roche
@Roche
New CE‑marked blood test complements MRI with a simple, minimally invasive option for more regular monitoring of neuroinflammation‑related activity in adults diagnosed with RRMS, supporting earlier and better‑informed clinical management. www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
Roche's future sequencing by expansion (SBX) could revolutionize next-generation sequencing (NGS) with an unmatched combination of flexibility, speed & accuracy. SBX’s versatility allows for tailored approaches, benefiting scientists and labs with improved understanding of diseases.
Step into this new era with SBX!
go.roche.com/sbxaoflx
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
Dr. Tester F. Ashavaid acknowledged that, in one of their studies, more than 50% of patients receiving the standard dose were sub-therapeutic.
Mass spectrometry can bridge this gap, supporting Therapeutic Drug Monitoring (TDM) to give clinicians precise, actionable insights.
Read more: go.roche.com/xorgmskol
#rochemassspec #tdm #diagnostics -
Roche
@Roche
Strategic vision requires world-class infrastructure and implementation. We are proud to announce the inauguration of Building 92 in Basel—a pivotal milestone in Roche’s R&D evolution.
As the new headquarters for @IHB_Research, B92 is more than a building; it is home to a multidisciplinary engine where we turn the potential of Human Model Systems into industry reality.
Find out more 👉 www.roche.com/media/releases/med-cor-2026-03-23 -
Roche
@Roche
#media - New survey demonstrates how diabetes limits day-to-day freedom for people around the world. The survey of 4,326 respondents revealed the significant mental and logistical burdens of managing diabetes, with 8 in 10 participants saying they would value predictive tools that for example can predict glucose changes before they occur.
#diabetescare #mentalhealth #healthtech
$ROG $RHHBY -
Roche
@Roche
#media – We are pleased to share data from our phase III study in systemic lupus erythematosus, being presented today at #sleuro and published in the @NEJM.
This study highlights the potential of our therapy to effectively reduce disease activity for this potentially life-threatening autoimmune disease.
👉www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
Thank you to @ISSSTE_mx in Mexico for your vision and commitment to making diagnostics a reliable guide for medical decision-making and patient care.
We are honored to partner with the healthcare system and its institutions to help transform care across the country by bringing more agile and precise care to more Mexicans. #somosroche
www.roche.com.mx/sala-de-prensa -
Roche
@Roche
#media - We’re pleased to share positive data from the third Phase III study for our investigational oral, brain-penetrant medicine in relapsing and primary progressive multiple sclerosis.
www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
What makes sequencing by expansion (SBX) so revolutionary? With ground-breaking speed and scalability, SBX, currently in development by Roche, delivers genetic insights faster than other popular technology.
More here: go.roche.com/xsbxtch
#genomics #humangenetics #rochesbx #innovation #ngs -
Roche
@Roche
#media – We are pleased the U.S. FDA has accepted Roche’s New Drug Application of our investigational medicine for ESR1-mutated, ER-positive, advanced #breastcancer. This news brings us closer to making this much-needed new treatment option available.
roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media – We are excited to share positive results from our trial in people with primary membranous nephropathy, the first global phase III study in this chronic autoimmune disease. #membranousnephropathy
www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
The leap to tomorrow is today! 🚀 Roche's new Diagnostics Innovation Center in Penzberg, Germany, is now officially open.
This €300M investment is a massive step for innovation, designed for collaboration and digitalization to accelerate test development. Better diagnostics = better lives for patients globally: go.roche.com/leapx
#innovation #leap #penzberg #healthcare #technology -
Roche
@Roche
Sequencing by expansion (SBX) is built to unlock opportunities that were once out of reach. From delivering full-length reads with unmatched speed to supporting transformative research, SBX, currently in development at Roche, sets a new benchmark for next-generation sequencing.
Watch the full video to find out more about how SBX is different from another popular sequencing technology!
go.roche.com/xsbxs
#genomics #humangenetics #rochesbx #innovation #ngs -
Roche
@Roche
MEDIA - We’re pleased to share new Phase III data at #actrimsforum for our investigational medicine in primary progressive multiple sclerosis.
👉www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
Roche reports strong 2025 results with 7% (CER) sales growth, driven by strong demand for medicines and diagnostic solutions.
👉 Read the full release here: www.roche.com/media/releases/med-cor-2026-01-29
$ROG $RHHBY #financialresults -
Roche
@Roche
It's #cervicalcancerawarenessmonth & we need to face the facts:
No woman should die from cervical cancer. This disease is highly preventable, yet hundreds of thousands of families still experience this devastating loss every year.
#screeningsaveslives -
Roche
@Roche
#media – We are pleased to announce that the US FDA has approved our bispecific antibody for subcutaneous administration, for people with relapsed or refractory #lymphoma, reducing administration time from 2-4 hours to approximately one minute. www.roche.com/media/releases/med-cor-2025-12-22
$RHHBY $ROG -
Roche
@Roche
Do you know how mass spectrometry can be used for therapeutic drug monitoring?
Enter a new dimension in mass spectrometry and find out how this diagnostic technique can help critically ill patients attain target concentrations.
go.roche.com/xtdms
#rochemassspec -
Roche
@Roche
The future of faster drug discovery may be on the horizon. #organoids, tiny simplified versions of human tissues, help us test potential medicines in faster, more predictive ways.
A new review with @Hubrecht Institute explores how.
👏 Thank you to the scientists driving this work.
Read more 👉 www.roche.com/stories/review-organoid-technologies
#drugdiscovery #innovation #pred @IHB_Research @Hans Clevers -
Roche
@Roche
#media - Roche receives CE mark approval for its automated mass spectrometry reagent pack for antibiotics drug monitoring, offering the industry's broadest #ivd menu on the mass spec platform. #rochemassspec
go.roche.com/xprmstdm
$ROG $RHHBY -
Roche
@Roche
#media — We’re excited to present transformational phase III data at #sabcs25 on our oral #serd vs. standard-of-care therapy in ER-positive early-stage #breastcancer roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU, providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media – We’re pleased to present new data highlighting the potential of our fixed-duration bispecific antibody in earlier treatment lines for people living with indolent and aggressive #lymphoma #ash25
👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media – We’re pleased to share three-year follow-up data from our off-the-shelf bispecific-combination which reinforce its potential to improve outcomes for people with an aggressive form of #lymphoma #ash25
👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
As the needs and expectations of people living with haemophilia A continue to evolve, Roche’s John Pasi explores how we can build on past breakthroughs to deliver more personalised care.
Read the full story 👉 www.roche.com/stories/haemophilia-a-care-innovation-future
#haemophiliaa #ash2025 #patientcentricity #innovationincare -
Roche
@Roche
Whooping cough (pertussis) results with PCR-level accuracy are now available at the point of care, enabling primary care clinicians & emergency departments to act quickly, treat appropriately, prevent complications, and control further spread.
www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
We’re proud to stand with the global scientific community at #ctad2025 to advance what’s possible in #alzheimer’s care.
For over 20 years, Roche has worked to change the trajectory of the disease - from early detection to ongoing care.
👉 Learn how we’re charting a new course in Alzheimer’s care: www.roche.com/stories/improving-the-patient-journey -
Roche
@Roche
Our #changingdiabetesinchildren initiative, in collaboration with @novonordisk, has spent 15 years empowering T1D care in resource-limited countries through education & access. Now, we're leveraging evidence-based insights to embed sustainable care into national health plans.
Witness our impact: go.roche.com/cdicx
#diabetesinchildren #diabetescare #healthequity -
Roche
@Roche
#media – We’re pleased to announce that the EC has approved our bispecific cancer immunotherapy for subcutaneous use in relapsed or refractory #lymphoma, providing an additional treatment option to suit diverse patient and physician needs. 👉 www.roche.com/media/releases
-
Roche
@Roche
#media — We’re pleased to share phase III results from the first oral #serd to show significant invasive-disease free survival benefit in ER-positive early-stage #breastcancer.
👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
At Roche, we are committed to pushing the boundaries of healthcare and making life-changing breakthroughs. Mass spectrometry is meeting the needs of the lab of the future for better patient care. Small chemistry enables big impact.
go.roche.com/aomsx
#rochemassspec -
Roche
@Roche
#media - We’re pleased to share positive Phase III results for our investigational oral, brain-penetrant medicine in primary progressive and relapsing forms of multiple sclerosis. www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
#diabetes doesn’t just impact the body; its unpredictability can also affect emotions, decision-making, and daily life. But what if people could know what was coming?
By harnessing predictive tools, Roche is making that vision a reality. Through the power of forecasting, we aim to let individuals living with diabetes gain control over their diabetes management.
Learn more here: go.roche.com/wddxcp -
Roche
@Roche
#media - Roche to showcase over 40 abstracts at #ash25, demonstrating the potential of our innovative portfolio to continue advancing treatment standards in #haemophiliaa and #lymphoma
👉 www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
#media – We are excited to share positive results from our phase III trial in systemic lupus erythematosus, a potentially life-threatening autoimmune disease that affects more than three million people worldwide.
👉 www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
New test delivers results in half the time or less compared to current comparable solutions, enabling faster patient management that can lower the risk of severe illness.
www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
New GUINNESS WORLD RECORDS™ title received! Our team, in collaboration with Broad Clinical Labs and Boston Children’s Hospital, achieved the fastest DNA sequencing technique: less than 4 hours to sequence a human whole genome! go.roche.com/xorgsbxwr
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
#media – We are excited to share positive results from our phase III trial in children and young adults with idiopathic nephrotic syndrome, the first global phase III study of a targeted therapy in this chronic disease.
www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
🚀 #proudmoment! Roche and @Genentech have been recognized among the world’s top #biopharma employers in @ScienceMagazine 2025 list! Congratulations to all our teams 👏💙
Read more about it here 👉🔗 www.science.org/content/article/2025-s-top-employers-inno…
#sctopemployers #innovationinhealthcare #science #biopharma @sciencecareers -
Roche
@Roche
[#media] Roche continues strong sales growth momentum of 7% (CER) in the first nine months of 2025; full-year earnings outlook raised. For more details on our performance, click here ➡️ www.roche.com/media/releases/med-cor-2025-10-23
-
Roche
@Roche
#media - We are pleased our phase III data at #esmo25 show personalised, ctDNA-guided treatment can deliver significant survival benefits for people with muscle-invasive #bladdercancer www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media - We are pleased the FDA has approved our medicine for adults with active #lupusnephritis, a potentially life-threatening disease that can lead to irreversible kidney damage. 👉 www.roche.com/media/releases
-
Roche
@Roche
#media - At #esmo25, we’ll be presenting results from the first positive head-to-head phase III trial of an all-oral #serd-containing regimen vs. a standard of care combination in ER-positive advanced #breastcancer www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
#media | This year at #aao2025, we’re pleased to share new phase III data for the first non-steroid targeted therapy designed to address inflammation driving #ume, a serious cause of vision loss. Learn more 👉 www.roche.com/media/releases/med-cor-2025-10-17b
-
Roche
@Roche
#media - We are pleased the CHMP has recommended approval of our investigational medicine for adults with #lupusnephritis, potentially helping to address the high unmet need for new treatment options if approved. 👉www.roche.com/media/releases/med-cor-2025-10-17
$ROG $RHHBY -
Roche
@Roche
A new GUINNESS WORLD RECORDS™ title is more than just a number — it’s a symbol of hope. Our teams at Roche, Broad Clinical Labs and Boston Children’s Hospital have achieved the fastest DNA sequencing technique, delivering data in record time. Find out more: go.roche.com/sbxwrgx
#ngs #genomics #innovation #makespacewithsbx #rochesbx -
Roche
@Roche
Roche data at #esmo 2025 showcase advances in science and cancer care across multiple tumour types. Read more here: www.roche.com/media/releases
-
Roche
@Roche
We send our sincere congratulations to Mary E. Brunkow, Fred Ramsdell & Shimon Sakaguchi, winners of the 2025 @NobelPrize. Their discovery of regulatory T cells was a breakthrough in immunology & developing potential therapies in autoimmunity, cancer & transplants. Join us in celebrating discoveries that inspire innovation & redefine healthcare. Join us in celebrating the 2025 @NobelPrize winners in Physiology or Medicine! Their visionary work and pioneering solutions are driving transformative progress.
Let's applaud these pioneers for their immense contributions and dedication! #nobelprize #immunology -
Roche
@Roche
#media – The US FDA has approved our #immunotherapy treatment regimen for extensive-stage small cell #lungcancer (ES-SCLC), where maintenance therapy may help combat the risk of progression www.roche.com/media/releases
$ROG $RHHBY -
Roche
@Roche
Honored to see @HansClevers recognized Abarca Prize in Spain! A remarkable achievement that demonstrates how science and compassion go hand in hand. Find out more about here:www.abarcaprize.com
#abarcaprize #researchprize #earlydevelopment #medicalresearch -
Roche
@Roche
Data show Roche’s innovations deliver improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies, helping clinicians quickly identify heart attack and rule out non-cardiac causes: www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
Sequencing breakthroughs are within reach! 🚀
Roche's SBX technology is set to accelerate genomics research while maintaining top quality and performance.
What do you see as the biggest advantage of faster, high-quality sequencing data analysis?
#genomics #science #biotech
Roche
@Roche
The answer is all of the above!
Faster, flexible and high-quality sequencing data analysis has the potential to bring incredible benefits to the world of science and healthcare!
Find out more here: go.roche.com/xsbxdapoll -
Roche
@Roche
#media - At #ectrims2025, we’re sharing new research on disability progression across broad MS populations. The findings reaffirm our collective commitment to advancing science and improving outcomes for the MS community.
www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
#media — Roche is pleased to share positive phase III results showing a significant progression-free survival benefit with our oral #serd for those living with ER-positive advanced #breastcancer. www.roche.com/media/releases/med-cor-2025-09-22
-
Roche
@Roche
Early recognition made all the difference for Silvia when her father was diagnosed with Alzheimer’s. In her words, caregiving is less about control and more about creating balance. #worldalzheimersday
Discover her story: 👉www.roche.com/stories/alzheimer-caregiving-silvia -
Roche
@Roche
#media – We are pleased the CHMP has recommended EU approval of a subcutaneous formulation of our bispecific antibody, potentially expanding the treatment options available for people with follicular #lymphoma
www.roche.com/media/releases
$RHHBY $ROG -
Roche
@Roche
[#media] Excited to announce that we entered into a definitive merger agreement with 89bio, a key step in tackling Metabolic Dysfunction-Associated Steatohepatitis (MASH), a serious liver disease linked to obesity. This move enhances our CVRM portfolio and deepens our commitment to metabolic health.
Read more: www.roche.com/media/releases/med-cor-2025-09-18 -
Roche
@Roche
As we age, the likelihood of developing #alzheimer’s disease increases. This makes early detection more important than ever, opening doors to better support, care planning, and new treatments.
Learn how Roche is charting a new course in Alzheimer’s care:
👉 -
Roche
@Roche
#media - At #euretina2025, we’re pleased to share promising data showing sustained vision gains & disease control in tough-to-treat eye diseases, like nAMD and PCV. www.roche.com/media/releases/med-cor-2025-09-05
-
Roche
@Roche
We’re pleased to share that our port delivery platform has received CE mark approval in Europe. This marks a significant step in advancing treatment for nAMD, the leading cause of vision loss in people over 60. www.roche.com/media/releases/med-cor-2025-09-04
-
Roche
@Roche
Participate and submit your innovative solution to the Ophtha Innovation Challenge (OIC) and make an impact for patients, caregivers & doctors.
👉 Apply now: go.roche.com/oicxorg
#roche #rocheoic #healthcareinnovation #ophthalmologychallenge -
Roche
@Roche
Next-generation sequencing (NGS) is revolutionizing healthcare by providing unprecedented genetic insights. Roche’s future sequencing by expansion (SBX) technology can lead the way in speed and flexibility.
Think you know what this tech can do? Which of the following is a key feature of NGS?
#genomics #ngs #makespacewithsbx #rochesbx
Roche
@Roche
The answer is all of the above!
Here are 5 fascinating things about NGS and how this technology is improving patient care around the world:
go.roche.com/xpollsbx5 -
Roche
@Roche
With dementia cases set to triple by 2050, the need for change is urgent.
The passion and innovation demonstrated at #aaic further fuel our commitment to transform the journey of people living with Alzheimer's disease. 👉 go.roche.com/aaicxgif -
Roche
@Roche
#media - We are pleased to be presenting new five-year data at #asrs2025 today. These data highlight that our refillable eye implant continues to provide long-term vision outcomes in neovascular age-related macular degeneration (nAMD) - the leading cause of vision loss in people aged over 60.
www.roche.com/media/releases/med-cor-2025-08-01 -
Roche
@Roche
For more than 20 years, we've been dedicated to transforming the #alzheimer's journey. At #aaic2025 and beyond, we remain committed to persevering through setbacks to advance the understanding, diagnosis and management of the disease. 👉 go.roche.com/aaicx3
-
Roche
@Roche
Join the Ophtha Innovation Challenge (OIC) to transform care for chronic retinal diseases. The need for continuing, long-term treatment of these diseases has resulted in critical information gaps that impact patients, caregivers, and doctors.
Bring your innovative solutions to bridge these gaps. Submit your proposal now at go.roche.com/oicxorg!
#roche #rocheoic #healthcareinnovation #ophthalmologychallenge -
Roche
@Roche
#media - We’re pleased to share new insights in Alzheimer's disease research across our diagnostics and treatment pipelines at #aaic25. The new data underscores Roche’s uniquely integrated end-to-end approach to addressing Alzheimer’s. www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
Momentum is building at #aaic2025 where science, collaboration, and determination are transforming #alzheimer's care.
At Roche, we’re proud to stand with the global scientific community to push the boundaries of what’s possible putting patients and families first. 👉 -
Roche
@Roche
Roche continues strong momentum with 7% growth (CER) in the first half of 2025 – full-year outlook confirmed. For more details on our performance, click here ➡️ go.roche.com/xhyr
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
#media — We are pleased to announce that the European Commission has approved our medicine for PIK3CA-mutated, ER-positive, HER2-negative, advanced #breastcancer, helping to address an urgent unmet need. go.roche.com/eucom
$ROG $RHHBY -
Roche
@Roche
#media - We’re pleased to announce we have received CE mark for our blood test to rule out Alzheimer’s disease. This minimally invasive test can reduce the need for additional confirmatory investigations. www.roche.com/media
$RHHBY $ROG -
Roche
@Roche
Mass spectrometry has the potential to provide patients with more personalised diagnoses.
But do you know what makes this technology a gold standard in clinical diagnostic testing?
Select your answer below.
#massspectrometry #innovation #diagnostics #rochemassspec
Roche
@Roche
The answer is all of the above!
Mass spectrometry enables better patient care through unparalleled specificity and accuracy.
Find out how Roche is shaping the future of clinical diagnostics here: go.roche.com/5ttkxpoll -
Roche
@Roche
Next-generation sequencing (NGS) plays an essential role in understanding the genetics of complex diseases. At Roche, we are leading the way with our breakthrough technology, sequencing by expansion (SBX).
Discover how SBX is revolutionizing genomics: go.roche.com/xsbxao08
#rochesbx -
Roche
@Roche
We're proud to renew our collaboration with The Global Fund to strengthen lab systems and diagnostics services that are essential for equitable access to care. Together, we leverage our expertise, resources and network to maximize our impact in low and middle-income countries.
go.roche.com/glfundx
#accesspartnerships
#globalhealth -
Roche
@Roche
#media We’re please to share that Phase I/II data presented at #isth2025 show that our investigational bispecific antibody may have the potential to provide haemostatic normalization in people with haemophilia A.
www.roche.com/media/releases/med-cor-2025-06-23 -
Roche
@Roche
We’re expanding affordable pricing for HPV DNA testing to support critical screening for an additional 50 million women living in LMICsUp.
go.roche.com/ccagapx
#cervicalcancerelimination #globalhealth #hpvtesting #roche -
Roche
@Roche
#media – We're pleased to share new late-breaking data at #18icml, showing that our investigational combination treatment could offer people with aggressive #lymphoma a well-tolerated option without traditional chemotherapy.
www.roche.com/media/releases/med-cor-2025-06-20
$RHHBY $ROG -
Roche
@Roche
Pharma and academia play distinct but complementary roles in driving innovation.
In a new @Nature article, @HansClevers shares insights on how bridging both worlds can accelerate progress in healthcare.
Read more here: rdcu.be/elPt8 -
Roche
@Roche
#media —We are advancing our investigational anti-alpha-synuclein antibody into Phase III development for early-stage #parkinsonsdisease www.roche.com/media/releases/med-cor-2025-06-16
$ROG $RHHBY -
Roche
@Roche
Antimicrobial resistance (AMR) is a pressing reality. The WHO projects that AMR could cause up to 10 million deaths annually by 2050 if current trends continue. Let's take action now to ensure life-saving medicines remain effective for future generations.
go.roche.com/xvidorg1
#amr #antibioticresistance #rocheamrThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media – We are pleased our Phase III data at #asco25, published in #thelancet, show survival benefits for people with small cell #lungcancer. SCLC is an aggressive cancer type where more options for disease control are highly needed: www.roche.com/media/releases/med-cor-2025-06-03 $ROG $RHHBY
-
Roche
@Roche
#media We are very encouraged about the Phase III data being presented at #asco25 by @Alliance_org in #coloncancer.
Huge thanks to Alliance, the investigators and patients taking part in this study.
$ROG $RHHBY -
Roche
@Roche
#media — We are pleased to be presenting new overall survival data at #asco25 for our medicine in people with advanced PIK3CA-mutated, HR-positive, HER2-negative #breastcancer, supporting standard of care potential. www.roche.com/media/releases/med-cor-2025-05-31
$ROG $RHHBY -
Roche
@Roche
#media — New 96-week data shows maintained near-complete suppression of disease activity and no disability progression for up to two years in people with relapsing multiple sclerosis.
www.roche.com/media/releases/med-cor-2025-05-30
#multiplesclerosis #clinicaltrials
$ROG $RHHBY -
Roche
@Roche
At Roche, we're committed to combating AMR with scientific collaboration and innovative diagnostics and treatments. We're at the forefront of scientific collaboration to improve patient access to the latest innovations.
#amr #antibioticresistance #rocheamr -
Roche
@Roche
Our world is moving toward faster, personalized diagnostics. Next-generation sequencing (NGS) leads the way by uncovering the genetics of complex diseases. At Roche, we're advancing NGS with our innovative sequencing by expansion (SBX) technology.
Learn more: go.roche.com/xsbxao25
#rochesbx -
Roche
@Roche
#media — We are pleased to announce a positive CHMP opinion for our medicine in advanced PIK3CA-mutated, ER-positive, HER2-negative #breastcancer, an aggressive subtype of breast cancer associated with a poor prognosis. www.roche.com/media/releases/med-cor-2025-05-23c $ROG $RHHBY
-
Roche
@Roche
#media – We are pleased to announce new two-year follow-up data at #asco25, showing an extended survival benefit with our off-the-shelf bispecific antibody combination, for people with an aggressive form of #lymphoma, after initial relapse. www.roche.com/media/releases/med-cor-2025-05-23 $RHHBY $ROG
-
Roche
@Roche
#media – We are happy to announce that the US FDA has approved our refillable eye implant for its third indication, diabetic retinopathy (DR) - a leading cause of #visionloss in adults with diabetes.
www.roche.com/media/releases/med-cor-2025-05-22
$ROG $RHHBY -
Roche
@Roche
Did you know that mass spectrometry can help tackle disease?
Enter a new dimension in mass spectrometry where vitamin D precision analysis can unlock personalized treatment plans for newborns and those in critical care.
go.roche.com/msvdx
#rochemassspec -
Roche
@Roche
#organoid atlases developed by @IHB_Research @ETH_en & @HelmholtzMunich are now part of the @humancellatlas —laying the groundwork for precision models & future therapies.
Built by global collaboration, powered by AI, designed to accelerate human disease modeling.
Find out more www.roche.com/stories/mapping-the-future-of-organoids
#humanbiology #biomedicalinnovation -
Roche
@Roche
Hypertension is a major global health challenge with 80% of cases remaining uncontrolled. We’re advancing holistic care to give people more control over their hypertension and health. Learn more here: www.roche.com/stories/improving-hypertension-care
#hypertension #cardiovascularhealth -
Roche
@Roche
#media — We are pleased to be presenting new ten-year data for our medicine in HER2-positive #breastcancer at #esmobreast25 today. These data reflect our continued commitment to addressing unmet needs for people diagnosed with breast cancer. www.roche.com/media/releases/med-cor-2025-05-13 $ROG $RHHBY
-
Roche
@Roche
#media — We are pleased the CHMP has recommended our medicine for HER2 - positive #breastcancer can be given outside of the clinic (at home) helping to alleviate the burden of treatment on people’s lives and freeing up cancer care capacity. www.roche.com/media/releases/med-cor-2025-04-30 $ROG $RHHBY
-
Roche
@Roche
#media - We are pleased to share that our Phase III study results, published in @NEJM, show a significant reduction in #influenza transmission from infected individuals to household members. www.roche.com/media/releases/med-cor-2025-04-25
$ROG $RHHBY -
Roche
@Roche
Roche continues good momentum into 2025 with a 6% (CER) sales growth in the first quarter. For more details on our performance, click here ➡️ www.roche.com/investors/updates/inv-update-2025-04-24
$ROG $RHHBY #financialresults -
Roche
@Roche
Introducing our CE-marked Chest Pain Triage algorithm in collaboration with @uniklinik_hd This advanced IVD device aids clinicians in triaging suspected NSTEMI patients in emergency departments for better patient care: www.roche.com/media/releases/med-cor-2025-04-23 #healthcare #innovation
-
Roche
@Roche
This #worldearthday, let’s unite for our planet! 🌍 We're committed to achieving net-zero by 2045, with @SBTi - approved targets.
Supply chains are crucial in reducing corporate carbon footprints, making collaboration with our partners essential for cutting emissions.
Roche
@Roche
Post not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media – We are pleased the EC has approved our first-of-a-kind bispecific antibody combination, for an aggressive form of #lymphoma, offering an off-the-shelf option for patients whose cancer returns or doesn’t respond to initial treatment. www.roche.com/media/releases/med-cor-2025-04-14 $RHHBY $ROG
-
Roche
@Roche
Alice Schlichtiger and her team have developed technology to make mass spectrometry widely available. The innovation could change the course of care, and deliver the best possible patient outcomes.
Read her story: go.roche.com/xmsstatic
#rochemassspec -
Roche
@Roche
We’re excited to announce that our net-zero targets have been validated by @sciencetargets! 🌍🎉
We’re committed to achieving net-zero emissions by 2045. 🌱
Learn more at: www.roche.com/stories/sbti-validation-for-net-zero-targetsPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
At this year's AGM, shareholders approved all proposals of the Board of Directors. CEO Thomas Schinecker emphasised our commitment to prioritise patients, to prevent, stop, and cure diseases while improving outcomes and reducing costs for patients and healthcare systems. #agm2025
Post not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
Our new report, ‘Decoding the Hepatitis Inaction Bubble’ reveals that stigma drives a harmful culture of silence, leading to a reluctance to test.
Click the link to learn more: www.roche.com/solutions/focus-areas/infectious-diseases/h…
#hepatitis #diagnostics #publichealth -
Roche
@Roche
We are excited to announce today’s exclusive collaboration and licensing agreement with Zealand Pharma to co-develop and co-commercialise their amylin-analog as a monotherapy as well as in combination with our key incretin asset. $ROG $RHHBY
Read more: go.roche.com/spndr25mr -
Roche
@Roche
We are thrilled to celebrate our member company, Chugai Pharmaceutical’s 100th anniversary today! Our alliance has brought benefits to patients worldwide. Here's to 100 more years of innovation! 🎉
Learn more at: www.roche.com/stories/chugai-100-anniversary
#chugai100thanniversary #roche -
Roche
@Roche
Alice Schlichtiger and her team are breaking new ground in mass spectrometry! With innovations aimed at faster, more accurate & personalised diagnostics, they're transforming patient care. Read her story in our #womeninscience series. go.roche.com/msliwisvideo
#rochemassspec -
Roche
@Roche
#media – We are pleased the U.S. FDA has accepted the supplemental Biologics License Application for our anti-CD20 monoclonal antibody, offering a potential new treatment option for people with active #lupusnephritis. $ROG $RHHBY
www.roche.com/media/releases/med-cor-2025-03-05 -
Roche
@Roche
During International #hpvawarenessday, read Vanessa Bennett’s article on HPV self-collection and join us in the fight to grow closer to a world without #cervicalcancer
Click the link to learn more: diagnostics.roche.com/global/en/healthcare-transformers.html
#healthcareinnovation #askabouthpv #eliminatehpv -
Roche
@Roche
#media We are pleased to share two late-breaking oral presentations featuring new Phase III data on our innovation in food allergies.
Learn more: www.roche.com/media/releases/med-cor-2025-03-02 -
Roche
@Roche
#media – We are pleased the CHMP has recommended EU approval of our off-the-shelf, bispecific antibody combination, offering a treatment that could be immediately available following relapse for people with an aggressive form of #lymphoma. www.roche.com/media/releases/med-cor-2025-02-28
$RHHBY $ROG -
Roche
@Roche
A new era in next-generation sequencing has begun with sequencing by expansion (SBX). Learn more and sign up to receive updates: go.roche.com/vidx25
#genomics #ngs #makespacewithsbx #rochesbx #agbtgm -
Roche
@Roche
With SBX technology, we’re entering a new space in next-generation sequencing – a space to dive deeper, accelerate results and gain richer insights from every sequence. Sign up to receive updates: go.roche.com/xstat23
#genomics #ngs #makespacewithsbx #rochesbx #agbtgm -
Roche
@Roche
#media - We are pleased to present our novel #sequencingbyexpansion (SBX) technology, creating a new category of NGS. The breakthrough SBX technology offers ultra-rapid, high-throughput sequencing that is both flexible and scalable.
go.roche.com/sbxpr20
$ROG $RHHBY -
Roche
@Roche
🌟 Rutas Saludables is delivering vital health screenings directly to women in rural Colombia who need them most. #togetherforchange #xproject #partnerships
Discover more at: www.roche.com/storiesPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media We are pleased to share full data from our Phase III study in #lupusnephritis, being presented today at the @ISNWCN and published in the @NEJM. This study reflects our commitment to advancing the treatment of kidney diseases. www.roche.com/media/releases/med-cor-2025-02-07
$ROG $RHHBY -
Roche
@Roche
What if we told you that our "super beads" are transforming #massspectrometry, making it easier, faster and greener? It's true. These beads help automate the testing process and cut down on plastic waste.
go.roche.com/superbeadsmsX
#rochemassspec #massspectrometry #innovation -
Roche
@Roche
#media – We are delighted to announce that the US FDA has approved our refillable eye implant to treat a leading cause of #visionloss in adults with diabetes – diabetic macular edema (DME).
www.roche.com/media/releases/med-cor-2025-02-04
$ROG $RHHBY -
Roche
@Roche
#media - We are pleased to announce FDA approval for first companion #diagnostic to identify metastatic breast cancer patients with ultralow #her2 expression eligible for a targeted treatment option. Learn more: www.roche.com/media/releases/med-cor-2025-01-31 #precisionmedicine $ROG $RHHBY
-
Roche
@Roche
#media Roche is pleased to share positive results showing our medicine has demonstrated a significant overall survival benefit for those living with advanced PIK3CA-mutated, HR-positive, HER2-negative #breastcancer $ROG $RHHBY
www.roche.com/media/releases/med-cor-2025-01-28 -
Roche
@Roche
Roche reports strong 2024 results with 7% (CER) sales growth; fourth quarter marks third straight quarter of 9% growth.
👉 Read the full release here: www.roche.com/media/releases/med-cor-2025-01-30
$ROG $RHHBY #financialresults -
Roche
@Roche
Self-collection is empowering women and people with a cervix to overcome barriers to HPV screening.
More are taking control of their health and moving us closer to a world without cervical cancer.
Watch the video to learn more.
#cervicalcancerawareness #hpvselfcollectionThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
According to the @WHO, 58% of cervical cancer deaths occur in Asia.
If detected early and managed effectively, cervical cancer is preventable and curable. With every test, we grow closer to a world without cervical cancer.
rochediagram.com/future-of-healthcare/the-battle-to-elimi… -
Roche
@Roche
#media We are pleased to announce that our molecular tests to diagnose sexually transmitted infections at the point of care have received FDA clearance with CLIA waiver in the U.S. Learn more here: www.roche.com/media/releases/med-cor-2025-01-22 $ROG $RHHBY
-
Roche
@Roche
What can help us grow closer to a world without #cervicalcancer?
Watch a film produced for us by @BBC StoryWorks to learn how self-collection, an innovative cervical screening solution to detect #hpv, is empowering the women of the Peruvian Amazon.
www.roche.com/stories/self-collection-peru -
Roche
@Roche
At Roche, we partner with biotechs, academia, and industry leaders to pioneer personalised, impactful healthcare solutions. Together, we tackle complex healthcare challenges of our time, improve outcomes, and shape the future of care. Learn more: go.roche.com/JPM25X #jpm2025
-
Roche
@Roche
HPV causes almost all cervical cancer. But our recent 12-country survey showed half the population has a limited understanding of it.
www.roche.com/stories/survey-hpv-cervical-cancer
With every HPV test, we're one step closer to a world without cervical #cancer. #cervicalscreening #womenshealth -
Roche
@Roche
At Roche, we are going beyond what was thought possible in diagnostics. Backed by science and led by #innovation, we are pushing boundaries today to advance the #healthcare of tomorrow.
In labs, for patients, for the world.
go.roche.com/MassSpecX
#rochemassspec -
Roche
@Roche
🌟“I am grateful to have the opportunity to do what I love and make an impact on people’s lives,” says Tebogo, a South African nurse who owns her own clinic through a local partnership.#togetherforchange #xproject #partnerships
Discover Tebogo's story at: www.roche.com/storiesPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media - We are pleased to announce the launch of our new solution to transform clinical mass spectrometry. Learn more: go.roche.com/MassSpecMediaRelease
#massspectrometry #innovation #diagnostics #rochemassspec
$ROG $RHHBY -
Roche
@Roche
🩺 Cancer patients deserve informed fertility choices before treatment. BeyondX empowers this journey. #togetherforchange #xproject
Learn more at: www.roche.com/storiesPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media – We are excited to announce that the pre-filled syringe of our bispecific antibody has received approval from the European Commission, for the treatment of three leading causes of #visionloss - nAMD, DME and RVO. www.roche.com/media/releases/med-cor-2024-12-13b
$ROG $RHHBY -
Roche
@Roche
#media - Roche is pleased to announce the CE Mark for the new and updated molecular cobas® 6800/8800 systems 2.0, enhancing laboratory efficiency and testing capabilities. www.roche.com/media/releases/med-cor-2024-12-13
#valueofdiagnostics #rocheinnovation
$ROG $RHHBY -
Roche
@Roche
#media – We are presenting new and long-term follow-up data on our fixed-duration bispecific antibodies at #ash24, reinforcing their potential to advance outcomes for people living with advanced #lymphomas.
➡️ www.roche.com/media/releases/med-cor-2024-12-10
$RHHBY $ROG -
Roche
@Roche
#media – We are pleased to present five-year follow-up data on our combination treatment at #ash24, the first to advance the standard of care in frontline diffuse large B-cell #lymphoma in 20 years
➡️ www.roche.com/media/releases/med-cor-2024-12-08
$RHHBY $ROG -
Roche
@Roche
🌟 Ashley is changing the facts on bleeding disorders for women and girls by bringing awareness to this often under diagnosed disease #togetherforchange #xproject #partnerships
Discover Ashley's story at: www.roche.com/storiesPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media – We are pleased the U.S. FDA has accepted our supplementary Biologics License Application for our bispecific antibody combination, offering a potential off-the-shelf treatment for an aggressive form of #lymphoma.
➡️ www.roche.com/media/releases/med-cor-2024-12-05
$RHHBY $ROG -
Roche
@Roche
At Roche, we are committed to innovation, developing pioneering medicines to deliver substantial patient benefits. Today, we are excited to announce that we entered into a definitive agreement to acquire @PoseidaThera . This acquisition will enhance our combined expertise, unlock new possibilities and pave the way for first-in-class therapies across various indications. #rocheinnovation #celltherapy #oncology $ROG $RHHBY
Read more: www.roche.com/media/releases/med-cor-2024-11-26b -
Roche
@Roche
We support World Antimicrobial Awareness Week! Everyone has a role in combating antimicrobial resistance #amr. Together, we can make a difference. Learn more about our fight against drug-resistant bacteria. 👉 www.roche.com/stories/antibiotics
#antimicrobialresistance #waaw #rocheamr -
Roche
@Roche
On the @WHO's Cervical Cancer Elimination Day of Action let’s increase understanding of #hpv. Together, we can eliminate cervical cancer with innovation, awareness and early detection. Learn more: www.roche.com/stories/survey-hpv-cervical-cancer
#cervicalcancer
#togetherforchange -
Roche
@Roche
🌟 Encaminadas provides full breast cancer care in Piura, removing the need for travel to get proper care.
Discover Luis'story at www.roche.com/stories
#togetherforchange #partnerships #xprojectPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
Mental health issues often affect people with #diabetes. Read the interview with Santiago to discover his secret weapons for protecting his mental well-being against the daily grind of diabetes management. www.roche.com/stories/diabetes-mental-health-advocacy
#worlddiabetesday -
Roche
@Roche
Not sure how to transform your workspace into a more diabetes-friendly environment? Shelley and other Roche colleagues living with #diabetes share tips on how to be more inclusive. Find out more: www.roche.com/stories/diabetes-mental-health-ally
#connectingwhatcounts
#worlddiabetesdayThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media - Roche to present more than 40 abstracts at #ash24, including long-term follow-up data for its lymphoma medicines, studies exploring alternative routes of administration and new investigational combinations in earlier treatment lines. www.roche.com/media/releases/med-cor-2024-11-05 $RHHBY $ROG
-
Roche
@Roche
Within few seconds, the global economy loses thousands of dollars due to the gender health gap.
Are you aware of the real costs of ignoring women’s health? Stay tuned for more insights! #togetherforchange #xindex
Find out more at: www.roche.com -
Roche
@Roche
The power of partnerships can transform healthcare. Through collaboration, we're paving the way in fighting breast cancer in Algeria. Learn more #togetherforchange #partnerships #xproject
Find out more on: www.roche.com/stories -
Roche
@Roche
#media - we are pleased to present new data at the 17th Clinical Trials in Alzheimer’s Disease congress (CTAD), demonstrating our growing momentum in diagnostics for Alzheimer’s disease. Learn more: www.roche.com/media/releases/med-cor-2024-10-31b
$ROG $RHHBY
#alzheimers -
Roche
@Roche
#media - We are pleased that phase III data for our medicine for people with advanced PIK3CA-mutated, HR-positive, HER2-negative breast cancer have been published in the New England Journal of Medicine.
Find out more on www.roche.com/media/releases/med-cor-2024-10-31 $ROG $RHHBY -
Roche
@Roche
🚀We are delighted to see three of our innovation engines on the prestigious @ScienceCareers 2024 Top Employers list!🔝
We would like to thank all the teams who made this achievement possible. We’re more motivated than ever to tackle the challenges that lie ahead!💪
Read more about it here: www.science.org/content/article/top-20-2024-who-did-scien…
Science Careers
@ScienceCareers
Congratulations to Insmed, @Regeneron, @Incyte, @VertexPharma, @Syngenta, @spark_tx, @Alnylam, @Roche, @Bioconlimited, and @genentech for making it to the top 10 in the Top Employers' rankings! #sctopemployers
👉View the full article online: www.science.org/content/article/top-20-2024-who-did-scien… -
Roche
@Roche
📢 Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months 👉 Read the full media release here: www.roche.com/media/releases/med-cor-2024-10-23
$ROG $RHHBY #rochefinancialresults #earnings -
Roche
@Roche
Through collaboration, exchanging ideas and rethinking solutions, we're pioneering the way to create positive change. #togetherforchange #partnerships #xproject
Find out more on: www.roche.com/stories -
Roche
@Roche
#media – We are pleased to announce data from a first-of-its-kind phase IV study in historically underrepresented people with diabetic macular edema, reflecting our commitment to diverse and inclusive research. www.roche.com/media/releases/med-cor-2024-10-18
$ROG $RHHBY -
Roche
@Roche
As a member of @TheSMI, we are proud to support this initiative with 25 top European universities, training 10,000 future doctors on the health impacts of climate change and delivering sustainable healthcare. Together, we’re building a healthier future!
👉www.sustainable-markets.org/news/leading-universities-to-…This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Any long-term condition, especially #diabetes, requires a holistic approach. Katharine Barnard-Kelly PhD, professor of health psychology, shares her perspective on how HCPs could support people with diabetes to navigate their mental well-being. Read more: www.roche.com/stories/diabetes-mental-health-doctor2doctor
-
Roche
@Roche
We’re proud to support this important initiative on Global PNH Awareness Day and stand with @GlobalPnh in our shared mission to improve the lives of people with PNH worldwide. #pnhawareness2024
PNH Global Alliance
@GlobalPnh
Today is Global PNH Awareness Day!🎉🌍Thank you for your support during our campaign. We've raised awareness and supported those affected by PNH. Stay tuned for more!. Let’s make every day a step closer to equal care and treatment. #pnhawareness2024 #treatingpnh
-
Roche
@Roche
#media — The FDA has approved our medicine for advanced HR-positive, HER2-negative #breastcancer with a PIK3CA mutation, one of the most commonly mutated genes in HR-positive disease, associated with poor prognosis. www.roche.com/media/releases/med-cor-2024-10-11
$ROG $RHHBY -
Roche
@Roche
🩺 Why do women wait longer for a diagnosis than men? It's time to address the gender health gap.
Let's stand #togetherforchange #xproject #partnerships #womenshealth
UNFPA does not endorse any company, brand, product, or service.
Find out more at: www.roche.com -
Roche
@Roche
#media - We are pleased to announce the first companion diagnostic test to receive CE Mark approval for determining CLDN18 protein expression in tumours of patients with gastric or gastroesophageal junction (GEJ) #cancer. Learn more: www.roche.com/media/releases/med-cor-2024-10-10 $ROG $RHHBY
-
Roche
@Roche
We’re proud to announce our partnership with #barda (@ASPRgov) to develop new diagnostic technologies that address traumatic brain injuries, a major public health burden.
Read the whole story here:
www.roche.com/stories/roche-barda-partnership -
Roche
@Roche
New global survey shows that half the population has a limited understanding of #hpv and its connection to cervical cancer. Download the Understanding HPV report here: www.roche.com/stories/survey-hpv-cervical-cancer
-
Roche
@Roche
Congrats to the @NobelPrize 2024 laureates Victor Ambros & Gary Ruvkun! Their discovery of #microrna revolutionised gene regulation and opened new avenues for medical research, impacting diseases like #cancer, #diabetes, and #autoimmunity. 👏 #nobelprize
The Nobel Prize
@NobelPrize
BREAKING NEWS
The 2024 #nobelprize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation. -
Roche
@Roche
How to create a lasting impact on Kenya's breast cancer care? Learn more www.roche.com/stories barriers through #togetherforchange #partnerships #xproject
-
Roche
@Roche
"Aliados por la Salud" is a multi-sectoral alliance that paves the way to ensure the right to health. #togetherforchange #partnerships #xproject
Find out more on: www.roche.com/stories -
Roche
@Roche
As World Alzheimer's Month wraps up, we’re reminded that the fight against this disease continues. At Roche, we aim for a future where an #alzheimers diagnosis helps preserve what makes us unique. Let’s fight the stigma and support families affected. #dementia @AlzheimerEurope
-
Roche
@Roche
#media – We are excited to announce first data from a phase III study in people with active #lupusnephritis. This study reflects our ongoing commitment to people living with kidney and kidney-related diseases. www.roche.com/media/releases/med-cor-2024-09-26
$ROG $RHHBY -
Roche
@Roche
Our R&D scientists have invented new TAGS technology to help diagnose respiratory illness. What lies at the core of this innovative method? Choose the correct answer from the options below 👇
#innovation #diagnostics #researchanddevelopment
Roche
@Roche
Find out more about the Temperature-Activated Generation of Signal (TAGS) technology 👉 www.roche.com/stories/new-tags-technology
#innovation #diagnostics #researchanddevelopment -
Roche
@Roche
Hear from Tamara Schudel, VP & Head of Global Policy, speaking at the @AtlanticCouncil Global Future Forum, where she discussed how medical #innovation not only improves outcomes for patients but can support economic growth.
Atlantic Council
@AtlanticCouncil
“We need to recognize that half the world’s population today doesn’t have access to medical services,” says @Roche’s Tamara Schudel at the #acglobalfutureforum.
“We need sustainable funding and financing for universal health coverage,” she tells @jmarczak. -
Roche
@Roche
The #honesttalk campaign reminds us of how important conversations between patients, families and healthcare teams are to help manage the emotional stresses that come with lymphoma and the fear of relapse. #wlad2024 #wlad
Lymphoma Coalition
@knowyournodes
This World Lymphoma Awareness Day, the global lymphoma community is encouraging everyone to have an Honest Talk. Living with lymphoma effects more than just physical health—it impacts emotional well-being too.
It’s time to get honest about how we’re feeling and start conversations that lead to getting the support needed.
If starting these conversations seems difficult, download our Honest Talk Conversation Starter. The digital postcard can be shared with medical teams or personal contacts to help open a dialogue.
The Conversation Starter and other materials are available at lymphomacoalition.org/world-lymphoma-awareness-day/ #wlad2024 #honesttalk #lymsm"This media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media — We are pleased to announce our first test to use breakthrough technology that can detect 12 respiratory viruses simultaneously on our high throughput analysers. Learn more: www.roche.com/media/releases/med-cor-2024-09-24 $ROG $RHHBY
-
Roche
@Roche
#media — We are pleased to announce that @WHO has endorsed dual-stain cytology testing in its #cervicalcancer prevention guidelines. Dual-stain cytology helps detect cervical precancer and may reduce unnecessary colposcopy procedures. Learn more: www.roche.com/media/releases/med-cor-2024-09-23
-
Roche
@Roche
Women with #multiplesclerosis face tough decisions when planning for parenthood. Explore insights from Amy VanBuskirk, Global SVP & Head of Neuro & Rare Diseases, on how we can better support their choices. #ectrims #ms
www.linkedin.com/pulse/ms-motherhood-exploring-complex-ch… -
Roche
@Roche
#media- We are pleased to announce that our #antiviral showed a significant reduction in the transmission of #influenza from an individual with the infection to household members in a Phase III study.
www.roche.com/media/releases/med-cor-2024-09-19
$ROG $RHHBY -
Roche
@Roche
What would you focus on to enhance your daily routine and improve your wellbeing, whether at work or home?
-
Roche
@Roche
In recognition of 20 years of #wlad, what are your hopes for the next 20 years in #lymphoma research?
Hear from Michelle Boyer, Global Head of Product Development, Lymphoma at Roche, who shares her hopes for the future of lymphoma care 👉 www.linkedin.com/pulse/its-time-discuss-psychological-bur…
#wlad2024 -
Roche
@Roche
#media The FDA approved the subcutaneous injection of our #cancer immunotherapy for certain lung, liver, skin and soft tissue cancer types. This approval is part of our commitment to offering patients and healthcare providers more options.
www.roche.com/media/releases/med-cor-2024-09-13
$RHHBY $ROG -
Roche
@Roche
#media We are proud to announce the inauguration of the Roche pRED Innovation Centre in Basel.
This new cutting-edge facility is ready to lead the way in medical research and innovation and deliver meaningful impact to patients.
Learn more here: www.roche.com/media/releases/med-cor-2024-09-10 -
Roche
@Roche
How to improve access and funding for cancer care in Nigeria? Learn more www.roche.com/stories how we transform health systems through #togetherforchange #partnerships #xproject
-
Roche
@Roche
Roche and SAS Brasil are joining forces to provide holistic solutions and better cervical cancer outcomes for women in Brazil. Learn more www.roche.com/stories #togetherforchange #partnerships #xproject
-
Roche
@Roche
🎙️ Listen to the newest episode of the #smamyway Podcast where Martyn and Josh discuss entrepreneurship and success and how #disability can affect them both! ✨ open.spotify.com/episode/5x4Cd5V1O88VIjECcQOb5x?nd=1&dlsi… #sma
-
Roche
@Roche
After an emotional four-day journey, our colleague Elisa and fellow dementia fighters reached Santiago de Compostela. Elisa met with Fernando Aguzzoli-Peres to share reflections on the "Walking the Talk for Dementia". #alzheimers #atlanticfellows
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Through local partnerships and diverse collaborations, we're dedicated to ensuring that women receive the treatment, diagnosis and care they deserve. Learn more www.roche.com/stories how we create a lasting impact in healthcare.
#togetherforchange
#xproject
#partnerships -
Roche
@Roche
This week, we will follow our colleague Elisa as she is “Walking the Talk for Dementia” across the Camino de Santiago and sharing her unique experiences. We at Roche are dedicated to stopping #alzheimers and dementia in its tracks. Be part of this journey. #dementia
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media – We are pleased to announce that the European Commission has approved our treatment for paroxysmal nocturnal haemoglobinuria in the EU.
Learn more: www.roche.com/media/releases/med-cor-2024-08-27
$ROG $RHHBY #pnh -
Roche
@Roche
XProject is joining forces to advance women's health. Our partnerships are reshaping global healthcare, breaking barriers and fostering meaningful change. Learn more www.roche.com/stories about our initiatives for healthcare equality #togetherforchange #xproject #partnerships
-
Roche
@Roche
🌟Scientists from #teamihb and @Roche #pred have made an exciting discovery that could help to better predict a drug’s effect on the body.🌟
🔬Significant research now published in @Nature.🚀
🎉 Check it out www.roche.com/stories/immune-upgrade-for-organoids
#rocheinnovation @IHB_Research -
Roche
@Roche
#media — We are supporting @WHO declaration of a global health emergency due to the ongoing #mpox outbreak with diagnostic tests developed for mpox, formerly known as #monkeypox. Learn more: www.roche.com/media/releases/med-cor-2024-08-20
$ROG $RHHBY -
Roche
@Roche
The average time for people to receive a lung cancer diagnosis after first noticing symptoms is often more than 6 months.
This delay can impact treatment options and outcomes. If you notice any persistent symptoms, don’t wait. Talk to your doctor and get checked early.
#worldlungcancerday
Learn more: www.roche.com/stories/about-lung-cancer
Roche
@Roche
How long do you think it takes, on average, for people to receive a lung cancer diagnosis after first noticing symptoms?
-
Roche
@Roche
🎙️ New episode live! Listen to the latest instalment of the #smamyway podcast to hear Martyn and Josh discuss travel and access and how #disability can affect them both ✈️ open.spotify.com/episode/49JoHCZeRGWLFjNzvukNw9?nd=1&dlsi…
-
Roche
@Roche
Today, in support of #worldlungcancerday, we want to highlight the importance of early diagnosis. #lungcancerawareness
Roche
@Roche
How long do you think it takes, on average, for people to receive a lung cancer diagnosis after first noticing symptoms?
-
Roche
@Roche
#media Our bispecific antibody has received approval from the European Commission for the treatment of macular edema secondary to retinal vein occlusion (RVO)–furthering our mission to save people’s sight from the leading causes of #visionloss. www.roche.com/media/releases/med-cor-2024-07-30 $ROG $RHHBY
-
Roche
@Roche
We are pleased to announce today the completion of the acquisition of @LumiraDx’s Point of Care diagnostics technology, enabling us to expand patient access to timely diagnostics results in decentralised healthcare settings worldwide.
$ROG $RHHBY
➡️ www.roche.com/media/releases/med-cor-2024-07-29 -
Roche
@Roche
🚀 We are driving innovation for those living with #alzheimersdisease! Our commitment to advancing diagnostics and new therapies shows our dedication to every aspect of the patient journey. 🧠💙
Discover more scientific advancements 👉 www.roche.com/stories/improving-the-patient-journey
#rocheinnovation -
Roche
@Roche
Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised.
For more details on our performance, click here ➡️ www.roche.com/media/releases/med-cor-2024-07-25
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
#media We’re proud to present new two-year data on two serious diabetic eye conditions for our refillable eye implant at #asrs2024. Additionally, the US FDA has accepted our application for the potential approval of the implant in these conditions.
www.roche.com/media/releases/med-cor-2024-07-18
$ROG $RHHBY -
Roche
@Roche
#media We’re happy to announce late-breaking data at #asrs2024 from the long-term study of our bispecific antibody for the treatment of DME - welcome news for the millions of people at risk of #visionloss.
www.roche.com/media/releases/med-cor-2024-07-17b
$ROG $RHHBY -
Roche
@Roche
Powerful insights ahead!🎙️
Tune in as we explore perspectives from people with #sma on the critical changes needed for adults living with this rare disease in Europe.
Don't miss the latest episode of the #smamyway podcast. 💬✨
open.spotify.com/episode/6xMPZc5kNIyMOqSkmAgn1s -
Roche
@Roche
#media - We are excited to announce that our AI-enabled #cgm solution offering
critical glucose predictions to people living with #diabetes has received CE Mark. Learn more: www.roche.com/investors/updates/inv-update-2024-07-09 -
Roche
@Roche
#media We are pleased to announce the reintroduction of our refillable eye implant in the US for the treatment of nAMD – the leading cause of #visionloss in people over the age of 60.
www.roche.com/media/releases/med-cor-2024-07-08
$ROG $RHHBY -
Roche
@Roche
🎧 Join our #movingscience #podcast with Prof. Dr. Gavin Giovannoni and PD Dr. Benjamin Friedrich as they discuss how the integration of advanced technologies has the potential to pave the way for a new era of MS care 🔍
Listen now: www.youtube.com/watch?v=z2N4Nb4XtLE #multiplesclerosis #ms -
Roche
@Roche
#media We are happy to announce that the U.S. FDA has approved the single-dose pre-filled syringe of the first and only bispecific antibody to treat three leading causes of #visionloss - nAMD, DME and RVO. www.roche.com/media/releases/med-cor-2024-07-05
$ROG $RHHBY -
Roche
@Roche
#media The #chmp has issued a positive recommendation for our bispecific antibody for the treatment of macular edema due to RVO – furthering our mission to save people’s sight from the leading causes of #visionloss.
www.roche.com/media/releases/med-cor-2024-06-28b
$ROG $RHHBY -
Roche
@Roche
#media We are pleased to announce that the CHMP has recommended EU approval of our treatment for #paroxysmalnocturnalhaemoglobinuria - a rare, life-threatening blood condition.
Learn more here: www.roche.com/media/releases/med-cor-2024-06-28 $ROG $RHHBY -
Roche
@Roche
#media - We are pleased to announce that @WHO has awarded prequalification to all of our #hpv screening solutions, allowing governments to expand national screening programs that help prevent #cervicalcancer. Learn more: www.roche.com/media/releases/med-cor-2024-06-27 $ROG $RHHBY
-
Roche
@Roche
#media We are pleased to announce the launch of two new analytical units which will deliver greater efficiency and capacity to #laboratories in CE mark countries. Learn more here: www.roche.com/media/releases/med-cor-2024-06-24 $ROG $RHHBY
-
Roche
@Roche
#media - We are pleased to announce the launch of our highly-sensitive Kappa and Lambda multiplex test to more easily diagnose patients that may have B-cell #lymphoma. Learn more: www.roche.com/media/releases/med-cor-2024-06-20 $ROG $RHHBY
-
Roche
@Roche
#media We are excited to announce late-breaking pivotal Phase III data being presented at #eha2024, which show that our off-the-shelf bispecific antibody combination significantly extends survival in people with an aggressive form of #lymphoma.
www.roche.com/media/releases/med-cor-2024-06-15
$RHHBY -
Roche
@Roche
🔧 Engineering New Gut Models 🔧
Innovative organoid-on-a-chip merges stem cell biology with advanced bioengineering for more accurate models for drug R&D, potentially leading to faster, safer and more tailored treatments for future patients.
Read more: www.roche.com/stories/modeling-the-gut -
Roche
@Roche
#smamyway Champion, Martyn, discusses the challenges of transitioning to adulthood with #spinalmuscularatrophy. Beyond finding new care assistance, it’s about adapting to new responsibilities and shifting dynamics.
Watch and hear Martyn’s experience.🔍 #smaThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
One walk, countless smiles. The Roche Children's Walk starts on June 11th, uniting colleagues globally to support children's education. Together, we're making a difference in #malawi, #ethiopia, #cambodia and more. Join us: www.roche.com/about/roche-global-citizenship/childrens-walk
#rochephilanthropy -
Roche
@Roche
The European Commission has delivered a landmark approval for our ALK inhibitor in resected ALK-positive lung cancer, with the potential to address an urgent unmet need and bring an important new treatment option to many more patients.
www.roche.com/media/releases/med-cor-2024-06-10
$RHHBY $ROG -
Roche
@Roche
#media We are pleased to announce that our four-in-one combination molecular test for #sarscov2, #influenza A/B viruses and #rsv has received U.S. FDA Emergency Use Authorization. Learn more: www.roche.com/media/releases/med-cor-2024-06-10b $ROG $RHHBY
-
Roche
@Roche
#media Today at the #2024smaconference we share 5-year data from the #firefish study, in children with Spinal Muscular Atrophy. Thank you to the children, families and all involved who have contributed to our understanding of #sma. @CureSMA www.roche.com/media/releases/med-cor-2024-06-07 $ROG $RHHBY
-
Roche
@Roche
#dyk Women are twice as likely to receive an incorrect diagnosis before being diagnosed with #heartfailure? Ensuring access to NT-proBNP testing can help optimise care while supporting effective use of healthcare resources. Learn more: www.roche.com/stories/cardiometabolic-timely-detection
-
Roche
@Roche
For 46 years, our partnership has delivered innovative diagnostic solutions, enhancing patient care globally. Excited for the future! www.roche.com/stories/roche-hitachi-partnership #partnership #diagnostics #innovation
-
Roche
@Roche
When it comes to navigating #multiplesclerosis, it’s helpful to have options. This #worldmsday, we’re committed to helping the MS community have options when it comes to managing their condition, as well as living healthy everyday. Find out more here: www.roche.com/solutions/focus-areas/neurology/multiple-sc…
-
Roche
@Roche
Advances in #breastcancer diagnostics create new treatment pathways for patients like Enisa. Learn how we elevate hope through breast cancer innovation. www.roche.com/stories/her2-low-patient
-
Roche
@Roche
We are pleased that the U.S. FDA has granted Priority Review to our investigational medicine for people with advanced PIK3CA-mutated, HR-positive breast cancer, an important step for these individuals who often have a poor prognosis.
www.roche.com/media/releases/med-cor-2024-05-29
$ROG $RHHBY -
Roche
@Roche
From overcoming challenges to celebrating victories, our journey with @CCan_org has been deeply rewarding. Stay tuned as we unveil our shared vision for the future! #roche #cancerinnovation #cancer #oncology Find out more here: www.youtube.com/watch?v=cxsSe1s3jUQ
-
Roche
@Roche
Hospitalisation is the biggest cost driver in #heartfailure management. Establishing national #cvd strategies leveraging cardiac biomarkers like NT-proBNP is the first step for creating better outcomes for patients and health systems. Learn more www.roche.com/stories/cardiometabolic-timely-detection #useheart
-
Roche
@Roche
Congratulations to Sylke Poehling for being awarded the title of Professor of Practice in the Department of Biosystems Science & Engineering. We at @Roche pRED look forward to deepening our collaboration and our scientific and educational exchange with @ETH_en.
ETH Zurich
@ETH_en
The ETH Board appointed twelve professors and awarded titles of "Professor" and "Professor of Practice" multiple times based on Joël Mesot's application. 👩🏫 ethz.ch/en/news-and-events/eth-news/news/2024/05/new-appo… @eth_math @Joel_Mesot @ETH_Rat @usys_ethzh @eth_dmavt
-
Roche
@Roche
We are delighted to share that the U.S. FDA has granted Breakthrough Therapy Designation to our investigational medicine for people with advanced PIK3CA-mutated, HR-positive breast cancer in recognition of its promising potential.
www.roche.com/media/releases/med-cor-2024-05-21
$ROG $RHHBY -
Roche
@Roche
#media We are pleased to announce that @FDA granted Breakthrough Device Designation of our blood test to support patients with #cardiovascular risk. Learn more here: www.roche.com/media/releases/med-cor-2024-05-22 $ROG $RHHBY
-
Roche
@Roche
#media – We’re pleased to announce the @FDA approval of our #hpv self-collection solution in the U.S. Learn more: www.roche.com/media/releases/med-cor-2024-05-15 #cervicalcancer $ROG $RHHBY
-
Roche
@Roche
Discover the wisdom of #smamyway Champion, Karli, as she reflects on her journey from 18. From navigating life with Spinal Muscular Atrophy (#sma) to embracing interdependence and redefining success, Karli's insights are empowering and enlightening.
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
🎧 The journey with #spinalmuscularatrophy (SMA) is unique for everyone, and the SMA My Way podcast is here to recognise and celebrate that.
Join us to listen to the powerful stories of our SMA My Way Champions: global.smamyway.com/resources -
Roche
@Roche
We are pleased that the CHMP has issued a positive recommendation for our ALK inhibitor in the adjuvant setting – an important step toward improving treatment outcomes in early-stage disease. www.roche.com/investors/updates/inv-update-2024-04-26
$RHHBY $ROG
#rocheinnovation #science -
Roche
@Roche
#smamyway Champion, Louise, shares her experiences of growing up with #sma and the transition from relying on her family to relying on personal care assistants. Read her blog here: global.smamyway.com/posts/personalcareassistance #spinalmuscularatrophy
-
Roche
@Roche
Roche & @WWF are proud partners on sustainability projects across #turkey, #pakistan & #vietnam. Learn more about our work in disaster response, forest restoration & community resilience: www.roche.com/about/roche-global-citizenship/disaster-relief
#conservation #togetherforchange -
Roche
@Roche
Roche sales increase by 2% (CER) in first quarter with both divisions growing high single digit ex COVID-19. We confirm our outlook for 2024. For more details on our performance, click here ➡️ www.roche.com/media/releases/med-cor-2024-04-24
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
We are delighted that the FDA has approved our ALK inhibitor for adjuvant use for people with resected ALK-positive early-stage lung cancer, furthering our aim to provide patients with the best chance for cure. www.roche.com/media/releases/med-cor-2024-04-19
$RHHBY $ROG
#rocheinnovation #science -
Roche
@Roche
Paulo Fontoura discusses the future of #multiplesclerosis care and how the latest advancements in scientific research are helping to provide new options for people with MS in managing their condition from diagnosis: www.linkedin.com/pulse/future-ms-care-how-scientific-prog…
-
Roche
@Roche
✨There is hope that Parkinson's will one day be eliminated. Recognition of the importance of certain protein formations has brought us to the brink of a revolution.
The goal: personalise medicine for each patient. 🌈
Check it out: www.roche.com/stories/redefining-parkinson-s-diseasePost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
#media
We are pleased to announce that our off-the-shelf bispecific antibody combination showed a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell #lymphoma in a Phase III study.
www.roche.com/media/releases/med-cor-2024-04-15
$RHHBY -
Roche
@Roche
#media: We are pleased to announce that @FDA granted Breakthrough Device Designation of our blood test to support earlier #alzheimer's disease diagnosis.
Learn more here: www.roche.com/media/releases/med-cor-2024-04-11
$ROG $RHHBY -
Roche
@Roche
#myhealthmyright isn't just a slogan! Roche partners with @m2mtweets Ghana to ensure healthcare access for mothers & children in Ghana. This #worldhealthday, join us in building a healthier world! 👉 www.roche.com/stories/supporting-community-health
#healthforall #mothers2mothers -
Roche
@Roche
#smamyway Champion, Louise, discusses her journey from childhood to adult care while living with spinal muscular atrophy (SMA). Hear her experience and the advice she would give her younger self.
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
#mystoryforchange gave voice to hundreds of women in the world to share their health stories.
Learn more about the results and what they uncovered here: www.roche.com/stories
#xproject #togetherforchange -
Roche
@Roche
#media - We are pleased to announce that Roche received @FDA approval for the first molecular test to screen for #malaria in blood donors.
Read more here: www.roche.com/media/releases/med-cor-2024-03-26
$ROG $RHHBY -
Roche
@Roche
Exciting news!🎉 Professor Juergen Knoblich @Knoblich_lab, a pioneer in #organoids & neurobiology, joins Roche as the Head of the Institute of Human Biology in #basel. His expertise will help us accelerate drug development. @IHB_Research's future looks bright! #rocheinnovation
Institute of Human Biology
@IHB_Research
🎇Big news! Prof Juergen Knoblich @IMBA_Vienna @oeaw @MedUni_Wien joins #teamihb as its new Head. Bringing extensive leadership experience, he is also a pioneer in #organoids biology. His lab was 1st to develop an organoid model for a human brain disorder. Welcome @Knoblich_lab!
-
Roche
@Roche
Countless women globally confront challenges in healthcare stemming from a pervasive misunderstanding of female health. We've reached out to them, and they told us their stories. Here are the results: www.roche.com/stories #xproject #togetherforchange #mystoryforchange
-
Roche
@Roche
Join our LinkedIn Live on the digital endpoints, on March 21st to hear the insights of Prof Jeffrey Statland from @KUMedCenter, Damien Eggenspieler and Paul Strijbos, Neurotech Innovation at @Roche. Register here: www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… #digitalendpoints #clinicaltrials
-
Roche
@Roche
Congrats on the milestone! Roche values strategy & teamwork for global patient innovation. Here's to a century more of healthcare breakthroughs in Belgium! #closethehealthcaregap #roche100yinbe
-
Roche
@Roche
#iwd2024 may have passed, but the work to bring about a more equitable future in healthcare is still ahead of us. Learn more about the challenges women face in healthcare and help us close the gaps: www.roche.com/stories
#mystoryforchange
#togetherforchange
#inspireinclusion -
Roche
@Roche
On #worldkidneyday, we're spotlighting our dedication to nephrology. 🌍 Roche is seeking ways to improve kidney health and patient lives. Together, we can make a difference! #roche #nephrology #healthcareinnovation #kidneyhealthforall
World Kidney Day
@worldkidneyday
Today we celebrate #worldkidneyday! Let's mark the day by advocating for #kidneyhealthforall! Share your activity with us, tag us on your social media posts, and we will be thrilled to share it on our social media channels! www.worldkidneyday.org/2024-campaign/ @ISNkidneycare @ifkf_wka
-
Roche
@Roche
Our shareholders have approved all Board proposals at our AGM. Our goal? Faster patient care. "Even in a marathon, every minute counts," says CEO Thomas Schinecker. Find out more here: www.roche.com/about/governance/annual-general-meetings
#healthcareinnovation #patientcare -
Roche
@Roche
Many patients don’t have the luxury of time on their side when it comes to unmet needs in healthcare. That’s why regulatory speed and agility are crucial to the timely assessment of new innovations. It was possible when all of society had that need in 2020. We’re urging it to be possible for smaller patient populations outside of a healthcare crisis. Read more at www.roche.com/stories/regulatory-speed-agility
-
Roche
@Roche
#iwd2024 is a great reminder of how far women have come, but it’s also a time to reflect on the work that still needs to be done.
#mystoryforchange elevates the voices of women shaping a fairer future. Learn more: www.roche.com/stories
#togetherforchange
#inspireinclusion -
Roche
@Roche
We’re pleased to announce - in collaboration with our partner @Alnylam - new phase II data in people with #hypertension (or high blood pressure), a growing global health crisis that affects one in three adults worldwide and is the leading cause of cardiovascular disease.
-
Roche
@Roche
✨Science changes lives 🧬
At Roche, we transform lives through groundbreaking science in neurodegenerative diseases like #alzheimer's & #parkinson's.
From diagnostics to treatments, we push boundaries to fight these complex disorders.
👉 www.roche.com/stories/science-alzheimers-diseasePost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
Over 630 women worldwide shared their stories with #mystoryforchange, exposing the inequalities they face in healthcare.
Join us in catalyzing the transformation in healthcare systems. Learn more here: www.roche.com/stories
#xproject #togetherforchange -
Roche
@Roche
You can read the full ‘Care for adults living with SMA in Europe’ benchmarking report here: odysma.sma-europe.eu/adult-care
Roche
@Roche
We are proud to partner with @SMAEurope on this vital report assessing standard of care for adults with spinal muscular atrophy (SMA) in Europe. Insights from 22 countries paint the most precise picture of adult care in SMA to date, uncovering the vital need for improvements.🔍
-
Post not available here, view on X
Roche
@Roche
We are proud to partner with @SMAEurope on this vital report assessing standard of care for adults with spinal muscular atrophy (SMA) in Europe. Insights from 22 countries paint the most precise picture of adult care in SMA to date, uncovering the vital need for improvements.🔍
-
Roche
@Roche
Can regulation keep pace with innovation? A sandbox can help. It’s a versatile framework within which regulators can explore and experiment to define the path of oversight requirements for the newly, truly novel. Find out more at www.roche.com/stories/future-innovation
-
Roche
@Roche
Interested in the transformative potential of digital endpoints? Join us and a panel of experts on March 21 to discuss how digital endpoints can bring change to clinical trials and patients. www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
#eupharmalegislation #digitalendpoints #clinicaltrials #digital -
Roche
@Roche
Only 3 weeks left until #ieepo2024! This empowering event gives patients the opportunity to have an equal voice in healthcare. Since 2008, IEEPO has fostered vital discussions and collaborations. Learn more: www.ieepo.com/en.html
-
Roche
@Roche
How might digital endpoints (measures captured by sensors on an ongoing basis) help the conduct of clinical trials?
#digitalendpoints #clinicaltrials #digitalhealth #digitalmeasures #unmetmedicalneeds -
Roche
@Roche
What if robust, clinical-grade data of a patient’s progress on a potential new medicine could be measured as they go about their activities of daily living? Whether at home or elsewhere.
#digitalendpoints can transform #clinical research and turn many what-ifs into reality.
Stay tuned for our upcoming LinkedIn Live on this exciting topic on 21 March. Join us here: www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
#clinicaltrials #digitalhealth #ema -
Roche
@Roche
👁️✨ Our #rnahub pioneers Ophthalmology Discovery with innovative #rnatherapeutics. Imagine long-acting treatments that revolutionise therapy and provide convenience for patients.
Stay tuned for exciting medical innovation and learn more here:
👉 www.roche.com/stories/rna-therapeutics-research
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
AI in healthcare is catching on and health systems are under duress. While AI isn’t the full answer, it can accelerate research and development and alleviate pressures on clinical care. But the framework of regulation needs to be fit for purpose. To ensure that Europe is a leader in healthcare’s digital transformation we reinforce our call for #sixboldactions for Regulatory Reform. Read more here: assets.roche.com/f/176343/x/76e723af10/sixboldactionsvn20…
#eupharmalegislation #healthcareinnovation -
Roche
@Roche
Did you know about the #ms Innovation Challenge? We have extended the submission period!
If you are a researcher or an a entrepreneur and have an innovative idea on how to best manage and maintain the health of people with #multiplesclerosis, we invite you to participate in the MS Innovation Challenge.
The selected top submissions will have the opportunity to acquire funding to bring their idea to life. Click here to learn more➡️ms-innovation-challenge.roche.com -
Roche
@Roche
🎙️Exciting news! A new #smamyway podcast episode just landed, featuring our Champion, Pia, and her mentor, Anna, as they tackle #leadership 🔥
youtu.be/en4Ou0pVrkI -
Roche
@Roche
In 2023, Roche's legacy of innovation responded to the world's healthcare needs. Together, we're advancing science and breaking new ground for a healthier future. #rochefinancialresults #healthierfuture #investinhealth #advancingscience
➡️ www.roche.com/investors/annualreport23 -
Roche
@Roche
At Roche, we’re extremely proud to support IEEPO - the next event will take place on March 13-14 and will focus on the pivotal role of patient organisations in shaping Universal Health Coverage (UHC) and Humanizing Healthcare together.🤝
#ieepo2024
👉 www.ieepo.com/en.html -
Roche
@Roche
🌟Adult stem cells: a biological universe still to be fully explored🌟 @BeumerJoep & @HansClevers review how we biologically define these cells and chart new research avenues that could lead to new medical innovation. More at www.roche.com/stories/defining-stem-cells
#rocheinnovation @IHB_Research -
Roche
@Roche
Addressing disparities in access to #cancercare is complex and requires stakeholder collaboration. At Roche, we take our shared responsibility to #closethecaregap seriously and are partnering to make long-term, sustainable change a reality. #worldcancerday www.youtube.com/watch?v=XQe7clrVIaA
-
Roche
@Roche
For too long, what makes an individual who they are or where they live has shaped their prognosis and outcomes. This #worldcancerday, we stand with the @uicc in calling for greater collaboration to #closethecaregap and ensure equitable #cancercare for all. www.roche.com/stories/world-cancer-day-2024
-
Roche
@Roche
🌟 Meet Antoine, our patient expert and MS advocate. His story of resilience and positivity is helping us reshape MS care at Roche. Discover how he's making a difference in our digital annual report. www.roche.com/investors/annualreport23 #msawareness #patientexpert #rocheimpact
-
Roche
@Roche
We’re pleased to announce positive long-term phase III data for our bispecific antibody for the treatment of macular edema due to retinal vein occlusion (RVO) – potentially reducing clinic visits and furthering our mission to save people’s sight from the leading causes of #visionloss. $ROG $RHHBY
go.roche.com/media-release-angiogenesis -
Roche
@Roche
2023: A year of concrete achievements and tireless commitment at Roche. Our efforts in oncology, ophthalmology and neurology led to changes that mattered. Find out the highlights in our digital annual report. $ROG $RHHBY #rochefinancialresults
www.roche.com/investors/annualreport23 -
Roche
@Roche
Our CEO Thomas Schinecker on the good results of 2023 📈
👉 Read the full release here: www.roche.com/media/releases/med-cor-2024-02-01
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
Each year, around 20 million people are diagnosed with cancer worldwide. For many, who they are or where they live determines their outcomes. Joanna Sicker and Tamara Schudel share what #roche and its partners are doing to #closethecaregap #worldcancerday
www.uicc.org/blog/bridging-cancer-care-gap-together -
Roche
@Roche
🚀 Breaking Boundaries in Brain Disease Treatment! 💡
Confronting the strong blood-brain barrier, scientists take a pioneering approach aiming to revolutionise #rnatherapeutics. Thrilled about the possibilities when technologies converge!🌐
👉www.roche.com/stories/crossing-barriers -
Roche
@Roche
What do you think are the barriers to cervical cancer screening?
Roche
@Roche
Watch a film produced for us by @BBCStoryWorks to learn more about our our partnership with the Peruvian Ministry of Health focused on empowering women to protect themselves against #cervicalcancer by using #hpv self-collection method. Learn more👇go.roche.com/CervicalCancerStories
-
Roche
@Roche
#dyk almost every case of #cervicalancer is caused by the human papillomavirus (#hpv)? Watch Unathi’s inspirational story of survival and learn how cervical screening can help prevent cervical cancer or find it early. www.roche.com/stories/prevent-cervical-cancer-through-scr…
-
Roche
@Roche
🎙️✨ New Podcast Alert! Dive into the latest episode where we explore the dynamic duo, Pia and Anna, who chat #mentorship and #emotionalintelligence. 🌟
open.spotify.com/episode/62OvuZ9xmiZUTNHJOeO89w?nd=1&dlsi…
#smamyway -
Roche
@Roche
#media: The subcutaneous (under the skin) injection of our #cancer immunotherapy has received approval from the European Commission for some of the most aggressive types of lung, liver, bladder and breast cancer. Learn more: www.roche.com/media/releases/med-cor-2024-01-16
-
Roche
@Roche
Inspiring survivor, Meaw, is on a mission to empower women to prioritise their health. Let's eliminate #cervicalcancer together. Early #hpv testing saves lives. For our loved ones and generations to come. www.roche.com/stories/prevent-cervical-cancer-through-scr…
-
Roche
@Roche
We join forces with policymakers, patient advocacy groups, healthcare providers and partners like @AmercianCancer, to help eliminate cervical cancer and raise awareness about #hpv. Learn more here www.roche.com/stories/fighting-cervical-cancer
#cervicalcancer #cervicalrt -
Roche
@Roche
🌟 We’re a unique partner for 3 reasons:
Long-term vision.
All-in-one expertise across Pharma, Dia, tech, & data
Collaborative and mutually beneficial partnerships.
Excited for #jpm2024 to transform lives together!
Learn more: www.roche.com/innovation/partnering/pharmaThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
What can bring us closer to a future free from #cervicalcancer? Watch a film produced for us by @BBCStoryWorks to learn how self-collection, an innovative cervical screening solution to detect #hpv, is empowering the women of the Peruvian Amazon. 👉 www.roche.com/stories/self-collection-peru
-
Roche
@Roche
Scientific progress is key to solving major global health challenges. Resistant bacteria today present a major threat. To outsmart them, our very dedicated scientists have now found a promising and surprising new path.
📷 Check out our latest discoveries in this field to address antimicrobial resistance #amr
www.roche.com/stories/new-era-of-antibioticsPost not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
🧬 Exciting mission at Roche! 🚀
At the forefront of innovation, we are confronting challenges in healthcare head-on.
With people at the heart, we are propelling advancements in #rnatherapeutics.
Find out more about what we are doing in #rnahub:👉www.roche.com/stories/rna-therapeutics-research -
Roche
@Roche
We are pleased to announce that @US_FDA granted Priority Review to a medicine for children and adults with #foodallergy based on positive interim results from a first-of-its-kind Phase III @NIH and @NIAIDNews study. Read more here: www.roche.com/media/releases/med-cor-2023-12-19
-
Roche
@Roche
In honour of #uhcday, we recognise our responsibility to engage in the collective effort to implement UHC. Our Joanna Sickler and Tamara Schudel share their views on recent op-ed to learn what the path towards #uhc looks like in practice: www.politico.eu/sponsored-content/how-the-world-gets-univ…
#healthforall -
Roche
@Roche
Over 20 years of a thriving partnership with Chugai! Grateful for the incredible innovations benefiting patients. Excited for the continued journey ahead! 📷 #allianceinnovation #healthcaresuccess
中外製薬
@chugai_cc
In 2002, Chugai started a strategic alliance with the Swiss company Roche. Under its unique business model, Chugai has realized its continuous growth.
In this video, we will present the financial impact of transactions with Roche.
youtu.be/Hl6A18BIBfo -
Roche
@Roche
Less than 30% of people with heart failure get diagnosed and treated on time. In a film featuring Rossana's journey and produced for us by @BBCStoryWorks, we aim to spotlight the crucial need for timely #heartfailure diagnosis 👉
www.roche.com/stories/maintaining-heart-health-as-you-age
#connectingthedots #vod -
Roche
@Roche
We are pleased to present new data at #ash23 from a Phase III study in infants with severe #haemophilia A without factor VIII inhibitors.
www.roche.com/media/releases/med-cor-2023-12-09
$RHHBY $ROG -
Roche
@Roche
We are pleased to present new and follow-up data from our bispecific antibody programme at #ash23, reinforcing our commitment to meeting the diverse needs of people with #lymphoma
www.roche.com/media/releases/med-cor-2023-12-11
$RHHBY $ROG -
Roche
@Roche
At the San Antonio Breast Cancer Symposium (@SABCSSanAntonio) on Friday, we presented follow-up data from a study of one of our medicines in HER2-positive early breast cancer. Find out more here: www.roche.com/media/releases/med-cor-2023-12-08b $ROG $RHHBY #sabcs23
-
Roche
@Roche
On Friday, we presented the first data from our phase III study in PIK3CA-mutated, HR-positive, HER2-negative breast cancer at the San Antonio Breast Cancer Symposium (@SABCSSanAntonio). Read more here: www.roche.com/media/releases/med-cor-2023-12-08 $ROG $RHHBY #sabcs23
-
Roche
@Roche
No two people diagnosed with cancer experience it the same way, and each person deserves a treatment plan tailored to their needs.
Discover how Brooke’s experience as a cancer nurse shapes her work at Roche here: www.roche.com/stories/once-a-nurse-always-a-nurse
#cancerawareness -
Roche
@Roche
The Roche Group’s mission to improve #healthcare is powered by strong #partnerships.
💡 Explore the power of partnerships with Roche Group and witness how collective expertise propels us towards transformative healthcare solutions:
www.roche.com/innovation/partnering -
Roche
@Roche
We are excited to share results from the primary analysis of a phase III study of one of our medicines in PIK3CA-mutated, HR-positive, HER2-negative breast cancer. Find out more here: www.roche.com/media/releases/med-cor-2023-12-05
$ROG $RHHBY -
Roche
@Roche
We are pleased to announce today’s agreement to acquire @CarmotTx, including three clinical-stage assets with best-in-class potential in obesity, diabetes and potentially other diseases.
$ROG $RHHBY
Read more: www.roche.com/media/releases/med-cor-2023-12-04 -
Roche
@Roche
Tune in to the first episode of the SMA My Way podcast - spotlighting Spinal Muscular Atrophy (SMA) on #disabilityday. Let's elevate the dialogue together. #idpd
-
Roche
@Roche
#media We are pleased to announce that our immunoassay to determine the presence and quantity of the #hepatitis B e antigen in human serum and plasma has received CE approval. Learn more here 👉 www.roche.com/media/releases/med-cor-2023-11-27 $ROG $RHHBY
-
Roche
@Roche
Biomarker testing may unlock more personalised care, yet many patients don't know about it or what to ask their doctor. It can be hard to know where to start.
If you or someone you know has lung cancer, download our checklist of questions to ask your doctor.👇
Roche
@Roche
This #lungcancerawarenessmonth we want to focus on the importance of biomarker testing.
People with #lungcancer are recommended to talk to their doctor about testing. What do you think is the biggest barrier to this? -
Roche
@Roche
There’s still time to register for the panel discussion on #realworlddata. We’re excited to share our line-up of experts who’ll be discussing its great potential in #europe and beyond. Register here ▶️ www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
-
Roche
@Roche
This #lungcancerawarenessmonth we want to focus on the importance of biomarker testing.
People with #lungcancer are recommended to talk to their doctor about testing. What do you think is the biggest barrier to this? -
Roche
@Roche
#worldcopdday has passed, and we hope that more and more people are aware of the #copd impact on people and healthcare.
We are committed to achieving significant relief for the broader #copd population and positively impacting public health globally. -
Roche
@Roche
#media We are pleased to announce that our immunoassays for the detection of #hepatitis E virus infection received CE mark approval. Learn more here: www.roche.com/media/releases/med-cor-2023-11-16 $ROG $RHHBY
-
Roche
@Roche
“When I was diagnosed, I didn’t know what biomarker testing was”. Lorraine recalls the days after her lung cancer diagnosis.
Join us this #lungcancerawarenessmonth and hear @markbrooke68 and Lorraine’s inspiring stories about why testing is important.
bit.ly/3MLuMuO -
Roche
@Roche
We are a proud partner of the Speak Up for COPD coalition in raising awareness of Chronic Obstructive Pulmonary Disease (COPD) and its challenges to patients, HCPs and policymakers.
It’s time to #speakupforcopd - Lend your voice to drive greater awareness of #copd.
Global Allergy & Airways Patient Platform
@gaapporg
It’s preventable and treatable, so why is chronic obstructive pulmonary disease the 3rd leading cause of death? Join us to #speakupforcopd alongside HCPs, NGOs, policymakers, patient advocates, and industry to make COPD a global health priority. www.politico.eu/sponsored-content/speaking-up-for-copd-a-…
-
Roche
@Roche
#media: The CHMP has recommended the subcutaneous injection of our #cancer immunotherapy for approval in the EU for some of the most aggressive forms of cancer. Learn more: www.roche.com/media/releases/med-cor-2023-11-14
$RHHBY $ROG -
Roche
@Roche
Interested in the value of #realworlddata for #patients, #science, health systems and society? Join us, and a panel of experts, on 30 November to discuss the growing momentum towards unlocking and leveraging real world data for improved patient outcomes: www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
-
Roche
@Roche
Although #copd is the third leading cause of death worldwide, there is still an urgent need for greater recognition of the impact of COPD on individuals and society to ensure people living with this disease receive the care they need and deserve.
Post not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
The #brainhealth crisis is overwhelming, with brain disorder cases increasing globally. We need to come together to drive change, which we’re hoping to achieve as part of
the Brain Health Collaborative.
Read more here in @politico ’s recent article: www.politico.eu/sponsored-content/a-united-front-against-… -
Roche
@Roche
On our journey to mark #worldcopdday, it’s vital that we know how impactful #copd is worldwide. Take a look at these three stats to understand the importance of #speakupforcopd.
Roche
@Roche
-
Roche
@Roche
#media We are pleased to announce that our immunoassay for Multiple Sclerosis received Breakthrough Device Designation from the U.S. Food and Drug Administration (@FDA). Learn more here. www.roche.com/media/releases/med-cor-2023-11-09
$ROG $RHHBY #msnews #multiplesclerosis #ms -
Roche
@Roche
Boosting diversity in research?
We’re excited to announce that Roche has just joined the @network_alba dedicated to increasing #diversity and #equity in #neuroscience research.
Learn more👉 www.alba.network/alba-network-partners-roche
Roche
@Roche
Roche
@Roche
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
Improvements in the diagnosis and treatment of #lungcancer in the earlier stages may help offer more people the opportunity to live their lives free from cancer.
Learn more about how doctors try to reduce the risk of lung cancer returning 👉 www.roche.com/solutions/focus-areas/oncology/lung-cancer
#lcam -
Roche
@Roche
#worldcopdday is November 15th, and from now until then, we want to show you how important it is to #speakupforcopd.
Let’s start this journey by explaining what COPD is.
Roche
@Roche
-
Roche
@Roche
At #ash2023 we are presenting more than 40 abstracts, showcasing our commitment to advancing treatment options and improving the lives of people with blood disorders
including #haemophiliaa and types of #lymphoma.
www.roche.com/investors/updates/inv-update-2023-11-02
$RHHBY $ROG #rocheinnovation -
Roche
@Roche
#media Today we announce Phase 3 results from a clinical trial investigating a gene therapy’s impact in #duchenne, a serious and progressive muscle-wasting disease, where new treatment options are urgently needed. Read more here: www.roche.com/media/releases/med-cor-2023-10-30
$ROG $RHHBY -
Roche
@Roche
🚀 Excited to see three of our innovation engines make it to the prestigious list @ScienceCareers 2023 Top Employers! 🔝
Our recipe for success? A wealth of passion, a good deal of autonomy, and the strength of our collective experience.
www.science.org/content/article/making-happy-workplace-em… -
Roche
@Roche
Lung cancer is a complex disease, and understanding the type and stage can open doors to more personalised treatment approaches.
Find out more about how biomarker testing can identify cancer subtypes and shape a patient’s treatment journey: www.roche.com/stories/biomarker-testing-lung-cancer -
Roche
@Roche
Our bispecific antibody has received approval from the U.S. FDA for the treatment of macular edema due to retinal vein occlusion (RVO) – furthering our mission to save people’s sight from the leading causes of #visionloss. $ROG $RHHBY
www.roche.com/media/releases/med-cor-2023-10-27 -
Roche
@Roche
Transforming healthcare through #rna innovation🧬
Exciting moments ahead as we gather around transformative objectives, firmly believing in the potential of #rnatherapeutics!
Find out more about our #rnahub:👉www.roche.com/stories/rna-therapeutics-research
#ots23Post not available here, view on X
Roche
@Roche
Roche
@Roche
-
Roche
@Roche
We are pleased to announce the acquisition of Telavant, providing us rights to a novel TL1A directed antibody, a promising new therapy for people suffering from inflammatory bowel disease and potentially multiple other diseases.
$ROG $RHHBY
Read more: www.roche.com/media/releases/med-cor-2023-10-23 -
Roche
@Roche
We’ll be tuning in to learn more about the Liver Cancer Index developed by @dice_europe and what we can do to reduce inequalities in the diagnosis and care for people with #livercancer across the EU.
Join the online event 👉 digestivecancers-eu.zoom.us/webinar/register/WN_azOnwX7hR…
Digestive Cancers Europe
@dice_europe
October is #livercancerawarenessmonth! Join us on the 25th for our online event for insights on #livercancer diagnosis & treatment & the launch of the Liver Cancer Index - mapping treatment practices in the 🇪🇺. Together, let's improve patient care.
👉 digestivecancers.eu/events/dice-online-event-together-ens… -
Roche
@Roche
Our CEO Thomas Schinecker on the good results of the first nine months of 2023 📈
👉 Read the full release here: www.roche.com/media/releases/med-cor-2023-10-19
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
📢 Roche reports good sales growth despite decline in demand for COVID-19 products
👉 Read the full media release here: www.roche.com/media/releases/med-cor-2023-10-19
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
🧬Exciting news: Together for CHANGE initiative launched! Roche joins forces with Meharry Medical College, Regeneron, AstraZeneca & Novo Nordisk to build the largest genomics research database of African ancestry.
Learn more 👉 www.businesswire.com/news/home/20231018288933/en/Together…
Roche
@Roche
Closing the gap on historical inequities in health care for underrepresented global Black communities 🌍🧬
Together for CHANGE will build more diversity in genetic research for people of African ancestry to address the disparities in healthcare, education, and training.
Roche
@Roche
Why this is important now:
Without a diverse database, the research and treatments being developed will never fully meet the needs of global Black communities.
We are at a revolutionary stage of science and technology so we must ensure diverse decision-making representation, consideration, and respect. -
Roche
@Roche
We are delighted to share that the Elecsys® IL-6 immunoassay has become the first IL-6 test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark. $RHHBY $ROG #sepsis
www.roche.com/media/releases/med-cor-2023-10-18b -
Roche
@Roche
We’re excited to share new data at #esmo23 from our study in early-stage ALK-positive non-small cell lung cancer, furthering our aim to provide the best chance for cure. www.roche.com/media/releases/med-cor-2023-10-18
$ROG $RHHBY #rocheinnovation #science -
Roche
@Roche
Building on our wealth of #multiplesclerosis data at #msmilan2023, we’re pleased to announce new late-breaking Phase II data highlighting brain penetrance, MRI and safety results in patients with relapsing MS: www.roche.com/media/releases/med-cor-2023-10-13 $RHHBY $ROG
-
Roche
@Roche
Self-care monitoring and medical exams are essential for early detection. Perseverance and seeking help are key to recovery, says Nadine Reemts, a Breast Care Nurse in Switzerland. Learn more here ➡️ www.roche.com/stories/recognise-breast-cancer
#xproject #breastcancer #earlydetection #womenshealth -
Roche
@Roche
During #msmilan2023, we’re presenting 10-year disability outcomes and safety data in patients with relapsing and primary progressive #multiplesclerosis, and pregnancy outcomes from 3,200+ women living with MS: www.roche.com/media/releases/med-cor-2023-10-12
$RHHBY $ROG -
Roche
@Roche
We are proud to be partnering with @IAPB1 this #worldsightday in their mission to raise eye health up the global agenda.
IAPB
@IAPB1
Happy #worldsightday!
Today, we celebrate how #loveyoureyes at Work resonates around the world and that workplaces are more productive and safer when eye care is accessible, available and affordable to all employees everywhere.
More at www.iapb.world/world_sight_day -
Roche
@Roche
Today, we will be participating in 'Making the Right decision for Me' in Milan. The panel discussion will present perspectives from both healthcare professionals and the #ms community. Follow this thread and learn more about this topic! #ectrims2023
Post not available here, view on X -
Roche
@Roche
We’re proud to announce late-breaking data at #msmilan2023 on subcutaneous administration pharmacokinetic, biomarker and MRI outcomes in patients with relapsing and primary progressive #multiplesclerosis: www.roche.com/media/releases/med-cor-2023-10-11
$RHHBY $ROG -
Roche
@Roche
We’re pleased to announce positive topline long-term phase III data for our bispecific antibody for the treatment of macular edema due to retinal vein occlusion (RVO) - a leading cause of #visionloss that affects around 28 million people globally.
www.roche.com/media/releases/med-cor-2023-10-10
$RHHBY -
Roche
@Roche
Early check-ups and taking preventive steps are key to staying healthy. Dina Rossi's story is a real-life example. Read it here ➡️ www.roche.com/stories/overcoming-cervical-cancer
#xproject #screenforlife #cervicalcheck #womenshealth -
Roche
@Roche
We are once again proud partners of @IAPB1 and #worldsightday this October 12. With just a week to go find out how you can get involved and #loveyoureyes❤️: www.iapb.world/world_sight_day
-
Roche
@Roche
The economic burden of #heartfailure is growing, resulting in a need for immediate action and investment to improve access to diagnostic solutions. Together we can help people live longer and healthier lives. Read more in @POLITICOEurope 👉 www.politico.eu/sponsored-content/putting-hearts-first-wh…
Roche
@Roche
What do you think can help make equitable access to #diagnostic solutions for #hearthealth a priority for health systems? #valueofdiagnostics
Roche
@Roche
Read more on how investing in healthcare can increase access to diagnostic testing globally, in order to improve healthcare for people worldwide. go.roche.com/AgingHealthily_T
@POLITICOEurope -
Roche
@Roche
#media We’re excited to share new data at the @WorldMuscleSoc Annual Congress from our study of the youngest babies with #spinalmuscularatrophy, adding to our knowledge of treating SMA before symptoms appear #wms2023
Read more: www.roche.com/media/releases/med-cor-2023-10-04
$ROG $RHHBY -
Roche
@Roche
Congrats to #nobelprize2023 winners Katalin Karikó @kkariko & Drew Weissman @WeissmanLab for pioneering #mrna in medicine. These pioneers have proven how innovative scientific approaches improve people’s lives. Optimistic about the future of #rna-based therapeutics.
-
Roche
@Roche
A truly moving story that reveals the importance of regular eye checkups.
At Roche, we recognize the importance of working and supporting eye health communities and #worldsightday this October 12 to deliver more and better health to everyone. www.bbc.com/news/uk-wales-66935226 -
Roche
@Roche
Today, we announced a new collaboration with Ionis to develop two novel treatments for Alzheimer’s and Huntington’s disease.
Teaming up with Ionis is a testimony to the strength of this partnership and the benefits both companies see in working together.
ir.ionispharma.com/news-releases/news-release-details/ion… -
Roche
@Roche
Disease relapse can be a significant source of fear and anxiety for people with #lymphoma
To support @knowyournodes, we're highlighting the need for additional treatment options that can reduce the risk of relapse, helping to improve emotional wellbeing
#wlad #wlad2023 #bloodcancer
Lymphoma Coalition
@knowyournodes
Did you know?
When compared to the general population, mental and emotional issues are more common in people who have been diagnosed with cancer.1
We Can’t Wait to Focus on Our Feelings.
Visit www.worldlymphomaawarenessday.org to learn more.
#wlad2023 #lymsm #lymphoma #bloodcancerawarenessmonth
1. Vehling S,Mehnert-Theuerkauf A, Philipp R, et al: Prevalence of mental disorders in patients with cancer compared to matched controls—Secondary analysis of two nationally representative surveys. Acta Oncologica 61:7-13, 2022. DOI:10.1080/0284186X.2021.1992008 -
Roche
@Roche
Our collaboration with @GustaveRoussy is a testament to our commitment to maximising patient access to genomic profiling.
Learn how powerful partnerships, like this, could help transform access to innovative cancer care solutions. www.roche.com/stories/partnering-to-bring-personalised-he…
#strongertogether -
Roche
@Roche
This #worldalzmonth we’re helping to raise awareness about dementia and the stigma it carries.
Read more about how we’re doing this here: www.roche.com/solutions/focus-areas/neurology/alzheimers
#alzheimersdisease #knowalzheimers -
Roche
@Roche
We are convinced that we need specific treatments for specific stages of the condition, and our vision is to provide much-needed treatment options for patients with multiple retinal conditions.
Please check it out: www.roche.com/stories/science-retinal-diseases
#rocheinnovation #ophthalmology -
Roche
@Roche
We extend our heartfelt sympathies to those impacted by the tragic earthquake in Morocco. All of our employees are safe. We are working with local authorities and partners to understand how we can support in the most impactful way and will update on our activities shortly.
-
Roche
@Roche
Three high-level meetings will occur at #unga78. Matt Sause, CEO Roche Diagnostics, stresses their importance as the world recovers from pandemic and tackles climate and humanitarian issues. Stronger #lab systems will be vital in the future. 👉 www.politico.eu/sponsored-content/labs-the-overlooked-bui… #uhc2023
-
Roche
@Roche
As one of the biggest global public health care crises facing society today, #alzheimersdisease is becoming increasingly prevalent globally. What’s the science behind this disease? ➡️ www.roche.com/solutions/focus-areas/neurology/alzheimers
#worldalzmonth -
Roche
@Roche
Find out how biomarker testing can play a pivotal role in a patient’s lung cancer care journey:www.roche.com/stories/biomarker-testing-lung-cancer-treat…
-
Roche
@Roche
How to define unmet medical need to best serve patients and society? Register now for our discussion on 11 September, to find out what a panel of experts think. www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
-
Roche
@Roche
It’s World Duchenne Awareness Day, & we’re proud to support the community by raising awareness of #duchenne
Learn more about this rare genetic disease that mostly affects boys by clicking on the link below.
#wdad2023
www.roche.com/solutions/focus-areas/neuroscience/dmd/ -
Roche
@Roche
Expanding access to strengthen global health systems should be our priority. On Sep 20, together with @ForeignPolicy we will host an event on the sidelines of #unga78 marking the 2030 #sdgs midpoint and coinciding with UN high-level meetings. Learn more: foreignpolicy.com/events/diagnostics-beyond-2030/
-
Roche
@Roche
We are pleased to announce positive phase III results for our ALK inhibitor, demonstrating our commitment to improving treatment options for early-stage lung cancers. www.roche.com/media/releases/med-cor-2023-09-01
$ROG $RHHBY #rocheinnovation #science -
Roche
@Roche
Great to see our very own Sascha Fauser interviewed in the latest issue of The Ophthalmologist about his vision for the future of eye health: theophthalmologist.com/issues/2023/articles/aug/a-vision-…
-
Roche
@Roche
Join us and a panel of experts on 11 September for a deep dive into criteria toward assessment of unmet medical needs. We’ll cover the current understanding, the #eupharmalegislation revision proposal, potential consequences, and alternative approaches. www.linkedin.com/events/unmetmedicalneeds7100767079426846…
-
Roche
@Roche
The Roche Group’s passion for innovation is as important as our passion for improving healthcare for all.
We provide all the tools to allow our researchers to follow their scientific passions and keep making breakthroughs.
Find out more here: www.roche.com/innovation -
Roche
@Roche
#media: The subcutaneous injection of our #cancer immunotherapy has received its first approval in Great Britain for some of the most aggressive cancers, including certain types of lung, bladder, breast and liver cancers. Learn more: www.roche.com/media/releases/med-cor-2023-08-29b
$RHHBY $ROG -
Roche
@Roche
#media The European Commission has approved our treatment for spinal muscular atrophy for those aged under two months, bringing another therapeutic option to even the youngest of babies living with #sma.
Read more: www.roche.com/media/releases/med-cor-2023-08-29
$ROG $RHHBY -
Roche
@Roche
Travelling can feel daunting, especially when you live with #spinalmuscularatrophy (SMA) so Shane and Hannah have some really helpful tips for your trip ✈️
To learn more about SMA this #smawarenessmonth check out @SMAEurope, or our site #smamyway: global.smamyway.comThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
This #smaawarenessmonth, Louise shares her bold journey from her parent's house to her own, living with Spinal Muscular Atrophy. 👩🦽
-
Roche
@Roche
"The Institute of Human Biology will be one of the world's research centers where revolutionary innovations will emerge and where we will get closer to the biology of human organs and diseases." - @HansClevers looks ahead to @IHB_Research in 10 years. 👇
#teamihb -
Roche
@Roche
When Shani’s husband was diagnosed with lung cancer, they were left thinking, ‘what next’?
For Shani’s husband, the next step was to test the cancer for characteristics called biomarkers.
Discover why biomarker testing is important in lung cancer 👉 www.roche.com/stories/biomarker-testing-lung-cancer -
Roche
@Roche
The correct answer is 1 in 10,000.
Learn more about #sma by following @SMAEurope, or by checking out #smamyway which highlights the experiences of people living with SMA: global.smamyway.com
Roche
@Roche
August is #smaawarenessmonth. Spinal Muscular Atrophy is a rare condition that has a lifelong impact on people’s lives. Do you know how many births are affected worldwide? 🌍
-
Roche
@Roche
As many as 64% of people with non-small cell lung cancer (NSCLC) have a genetic biomarker.
Learn why biomarkers are so important in lung cancer 👉www.roche.com/stories/biomarker-testing-lung-cancer
Roche
@Roche
Characteristics called biomarkers can help unlock the unknown in lung cancer. How many people with non-small cell lung cancer (NSCLC) have a genetic biomarker?
-
Roche
@Roche
We are proud to be a partner in this coalition and making #copd a priority.
Together, let's #speakupforcopd.
Global Allergy & Airways Patient Platform
@gaapporg
Chronic obstructive pulmonary disease (#copd) is the third leading cause of death worldwide, yet a recent poll shows it remains poorly understood and under-recognised.
Join us to #speakupforcopd and make it the public health priority it needs to be: www.who.int/news-room/fact-sheets/detail/the-top-10-cause… -
Roche
@Roche
August is #smaawarenessmonth. Spinal Muscular Atrophy is a rare condition that has a lifelong impact on people’s lives. Do you know how many births are affected worldwide? 🌍
-
Roche
@Roche
Roche is committed to giving our innovators the freedom to find answers, their way.
With a culture that allows creativity and innovation to thrive, our teams collaborate to tackle big healthcare challenges.
Learn more about our approach to innovation careers.roche.com/global/en -
Roche
@Roche
#worldlungcancerday is an important reminder of the challenges still faced by patients across the world.
Mark from @Lungfoundation shares his personal story as a caregiver and sheds light on the potential of biomarker testing.
www.roche.com/stories/biomarker-testing-lung-cancer -
Roche
@Roche
Characteristics called biomarkers can help unlock the unknown in lung cancer. How many people with non-small cell lung cancer (NSCLC) have a genetic biomarker?
-
Roche
@Roche
Did you know that #publichealth relies on fast and effective #diagnostic testing? Learn why 👉 www.roche.com/about/business/diagnostics/value-of-diagnos…
#valueofdiagnostics -
Roche
@Roche
Our CEO, Thomas Schinecker, comments on the Group's achievements in the first half of the year. Read more: go.roche.com/HY2023 #rochefinancialresults $ROG $RHHBY
-
Roche
@Roche
H1 2023, both our divisions' base business sales grew strongly, largely offsetting the COVID-19 products' reduced demand. We achieved pipeline milestones, including the US and EU approvals of a new blood cancer medicine. $ROG $RHHBY go.roche.com/HY2023
-
Roche
@Roche
We are pleased to announce a new partnership with @Alnylam to develop an investigational RNAi therapy to treat patients with hypertension at high cardiovascular risk.
$ROG $RHHBY
Read more: www.roche.com/media/releases/med-cor-2023-07-24 -
Roche
@Roche
#media The CHMP has recommended EU approval of our treatment for spinal muscular atrophy (#sma) in babies under two months, an important step towards bringing more therapeutic options for all ages and stages of SMA. www.roche.com/media/releases/med-cor-2023-07-21
$ROG $RHHBY -
Roche
@Roche
We have a key role to play in the pandemic preparedness ecosystem ensuring that safe & effective antivirals are ready when the next pandemic strikes. Learn more about what Roche and @genentech are doing in the interest of people’s health 👇
www.intrepidalliance.org/news/pharmaceutical-companies-pa… #science -
Roche
@Roche
We are excited to present new clinical and #realworlddata at the upcoming #asrs2023 meeting, showing improved outcomes for people with two leading causes of #visionloss. www.roche.com/media/releases/med-cor-2023-07-20 $ROG $RHHBY
-
Roche
@Roche
We are pleased to announce positive Phase III results for Roche’s twice-a-year, 10-minute subcutaneous injection therapy in patients with multiple sclerosis. An ongoing commitment to improving the lives of people with #ms
www.roche.com/media/releases/med-cor-2023-07-13 -
Roche
@Roche
We’re pleased to announce that the EC has approved our fixed-duration, off-the-shelf cancer immunotherapy for patients with relapsed or refractory diffuse large B-cell #lymphoma, the first therapy of its kind in Europe. www.roche.com/media/releases/med-cor-2023-07-11
$ROG #rocheinnovation #science -
Roche
@Roche
The @EANeurology Congress showed great progress in brain disorders, but our biggest challenge is how little we know about the global burden of #brainhealth.
Joseph Dieleman from @IHME_UW talks about this burden and why data is critical to understanding how to address it #ean2023 -
Roche
@Roche
The world is losing sight at a growing rate, according to a new paper developed in collaboration with @IAPB1 and @Deloitte. Read how we can, and should, address this through appropriate prioritisation and investment in #eyehealth: www.deloitte.com/ch/en/Industries/life-sciences-health-ca…
-
Roche
@Roche
Together with @ETH_en , we want to spearhead the biomedical revolution!
We firmly believe in jointly training the next generation of researchers working on translationally relevant challenges.
Check it out: next-gen-bioengineers.ethz.ch
#strongertogether #rocheinnovation -
Roche
@Roche
Our #childrenswalk Ambassador Anna visited #ethiopia 🇪🇹, witnessing @UNICEF's impact through the ""Child to Child"" program. Her story echoes our #rochephilanthropy mission: building connections, changing lives ❤️
Read her story🔗 go.roche.com/20-stories-anna-goshko -
Roche
@Roche
#media We’re excited to share new data at @CureSMA from our 4-year pivotal study of infants, now young children, living with spinal muscular atrophy. Our commitment to the community spans all ages & #sma types. #2023smaconference $ROG $RHHBY
Read more: www.roche.com/media/releases/med-cor-2023-06-30 -
Roche
@Roche
We believe that every woman has a universal right to good health. It's time to #changethefacts and give #everywoman a voice to get the healthcare they deserve.
#xproject #freedomtobeThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
When her daughter came out, Claire’s approach to allyship took on a new meaning. 🏳️🌈 From personal acceptance to championing inclusivity at Roche, learn how she solidified her support for the LGBTQIA+ community. #rochepride #itstartswithme #pride2023 ➡️ go.roche.com/mother-allyship
-
Roche
@Roche
Grab your headphones 🎧 and listen to the latest BIOs podcast to dive into the past, present, and future of human model systems with our Head of Pharmaceutical Research and Early Development (pRED), @HansClevers, and @DonIngber, Founding Director @wyssinstitute.
BIOS
@bios_community
Roundtable✨ - Human Model Systems w/ Don Ingber @wyssinstitute & Hans Clevers @Roche
Tune in to our newest @bios_community Roundtable episode w/ @DonIngber & @HansClevers debating the future of human models in biology 🧫
See our episode below...
www.youtube.com/watch?v=8uztHHz9cTA&list=PLt1wqID0Jg0-4qz… -
Roche
@Roche
According to a new paper, in collaboration with @Deloitte and @IAPB1, more than $410 billion was lost in economic productivity in 2020 due to sight loss. But hope is in sight, read to learn more about how governments can take action to prioritize #eyehealth:
IAPB
@IAPB1
📣 New report!
“As this report outlines, investment in eye care services is now critical to avoid escalating social, education and economic challenges in the near future.”- Peter Holland, CEO, IAPB.
www.iapb.org/news/governments-missing-opportunities-to-in…
@Deloitte @Roche
#newreport #eyehealth #economic -
Roche
@Roche
June is #myastheniagravis (MG) awareness month. At Roche, we advocate for those living with MG and their loved ones by helping to raise awareness of this rare, chronic autoimmune neuromuscular disease. Learn more here: myasthenia.org/MG-Education
#mgstrong -
Roche
@Roche
Many girls in Malawi miss weeks of school simply due to having their period. UNICEF, with our charity Re&Act, is tackling stigma around the topic. Read Bridget’s story to see how in our '20 Stories of Impact'. 👉 go.roche.com/20-stories-of-impact-bridget #childrenswalk #20yearsofimpact
-
Roche
@Roche
Leaders play a pivotal role in fostering safe and inclusive work environments. 🌈 Learn about Stuart's journey of coming out in the workplace, and how he's now using his experience to help others at Roche. #rochepride #itstartswithme #pride2023 ➡️ go.roche.com/key-to-diversity-is-authenticity
-
Roche
@Roche
Roche is committed to giving innovators the freedom to find answers, their way.
With a culture that allows creativity and innovation to thrive, our teams collaborate to tackle big healthcare challenges.
Learn about our autonomous approach to innovation careers.roche.com/global/en -
Roche
@Roche
What if we could create new drugs that work to cut off the disease-causing information flow in our bodies? Sounds good, right?
This ambitious aim is the mission of our new RNAHub in Basel.
👉www.roche.com/stories/rna-hub -
Roche
@Roche
In more than 70 countries, +160 sites: 1 mission - making a difference in children's lives. Thanks to all our #colleagues who walked at 20th #rochechildrenswalk! Proud to partner with @UNICEF, @ChildsDream, @SELAMCharity. One step, one heart, one dream. 👉 go.roche.com/20-stories-of-impact
-
Roche
@Roche
We are pleased to announce the U.S. FDA has approved our fixed-duration cancer immunotherapy for adult patients with relapsed or refractory diffuse large B-cell #lymphoma. www.roche.com/media/releases/med-cor-2023-06-16 #rocheinnovation
-
Roche
@Roche
Identity is more than a label — it's a journey. 🛤️ For Julie, their path to self-discovery led them to embrace their non-binary identity. 💪 Dive into their story of acceptance, support, and advocacy. #rochepride #itstartswithme #pride2023 ➡️ go.roche.com/acceptance-journey
-
Roche
@Roche
Living openly or hiding who you are? B. is a LGBTQIA+ professional, knows this struggle all too well. He experienced acceptance in the US but faces restrictions in South East Asia. His story reminds us: Inclusion is global. 🌍🏳️🌈 #pride2023
👉go.roche.com/balancing-two-selvesThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
The societal cost of #cervicalcancer, which kills more than 340,000 women and people with a cervix each year, is far greater than the cost of #prevention programs. Greater access to testing can help eliminate this disease. Learn more 👉 www.roche.com/stories/cervical-cancer-prevention-partners…
-
Roche
@Roche
#media - We are pleased to announce that @WHO has awarded prequalification to our test that detects #hpv. Now, governments can expand their national screening programs that help prevent #cervicalcancer. Learn more 👉 www.roche.com/media/releases/med-cor-2023-06-13
-
Roche
@Roche
It’s not just building schools, it’s building whole communities.' Learn more about inspiring stories like Yem Khlok's journey and their profound impact during the 20 years of the Roche Children’s Walk. 👉 go.roche.com/20stories-yemkhlok
#childrenswalk #20yearsofimpact #rochephilanthropy -
Roche
@Roche
Antoun went from facing discrimination in his home country to being a courageous #lgbtqia+ advocate at @Roche_BeLux 🌍. His story is a reminder that change is possible and that love will always win ❤️🧡💛💚💙💜. 👉 go.roche.com/fostering-inclusive-environments #rochepride #itstartswithme #pride2023
-
Roche
@Roche
We are pleased to present the first global data from our phase III programme in paroxysmal nocturnal haemoglobinuria (PNH), reinforcing our commitment to improving the lives of people with #pnh around the globe. www.roche.com/media/releases/med-cor-2023-06-09
-
Roche
@Roche
Partnering is essential to how we innovate. We look forward to meeting many current and prospective collaborators at #bio2023. Hear more about our unique approach to partnering in our pursuit to tackle the big questions in healthcare. Learn more: www.roche.com/innovation/partnering/pharma/
-
Roche
@Roche
20 years of the Children’s Walk! This initiative has transformed lives, involving 328K+ employees and benefiting 10M+ people. Learn more 👉 go.roche.com/20-stories-of-impact.
Thanks to all our partners! #childrenswalk #20yearsofimpact -
Roche
@Roche
This #worldmsday we’re proud to hear from the #multiplesclerosis community around the world as they discuss how despite their MS, they continue to pursue the things they love most and live life to the fullest: URL #msconnections
www.roche.com/stories/portraits-of-ms -
Roche
@Roche
Blood in urine? Be sure it’s not #bladdercancer and #getchecked❗ #bladdercancermonth23 #unsureicon
World Bladder Cancer Patient Coalition
@WorldBladderCan
📣 Many symptoms of bladder cancer could at first appear to be something else entirely. Be sure it’s not #bladdercancer.
Get involved today! 👉 worldbladdercancer.org/awareness-month/
#bladdercancermonth23 #unsureicon #getchecked -
Roche
@Roche
The #euromedlab2023 has begun! Together we can start building an intelligent and integrated lab to generate insights for better care. Visit us at booth 59 to find out more. ➡️ event.roche.com/eml2023/index.html?sid=bafdf8430f6b787877…
Roche
@Roche
Sometimes an evolution in the #lab is not enough. Join us now at booth 59 to see Roche unveil the latest revolution for your laboratory. ➡️ event.roche.com/eml2023/index.html?sid=bafdf8430f6b787877… #euromedlab2023
Roche
@Roche
We are looking forward to seeing you today at #euromedlab2023. Step by our booth 59 to meet the team and learn more about the latest innovations in diagnostics.
-
Roche
@Roche
Innovated solutions help clinicians in improving care for patients. Learn how #cardiac biomarkers can provide critical information to maximize healthcare professionals' confidence in decision-making in hospital settings and primary-care. diagnostics.roche.com/global/en/products/product-category… #beatcvd
-
Roche
@Roche
At the Roche Group, we are driven by our passion for discovery and improving healthcare for all.
We have been committed to advancing healthcare for more than 125 years. Our partnerships allow us to collaborate and keep this passion alive.
Learn more here: www.roche.com/innovation/partnering -
Roche
@Roche
A promising tool for advancing #personalizedmedicine: Drugs can be tested on #organoids to help predict how individual patients might respond to treatment.
👉Learn more about the findings of @IHB_Research and the collaboration between Roche and academia: institutehumanbiology.com -
Roche
@Roche
Roche and Chugai teamed up over 20 years ago on a mission to enhance the lives of patients worldwide through groundbreaking treatments. Our symbiotic partnership accelerates pioneering innovation, delivering new treatments to patients in Japan and worldwide. #strongertogether
中外製薬
@chugai_cc
In 2002, Chugai started a strategic alliance with Roche, one of the world's leading pharmaceutical companies. Under its unique business model, Chugai has realized its continuous growth.
Pls check out video for this unique business model !
youtu.be/d7JSPJuZefw -
Roche
@Roche
Today is International Huntington’s Disease Awareness Day, and we hear from Lesley on how she balances caring for her father and living #huntingtonsdisease, while also managing her own diagnosis and planning for the future. Find your local HD group here: eurohuntington.org/huntingtons-disease-associations/
-
Roche
@Roche
Since the 1960s, we at Roche have been developing innovative #diagnostic solutions. Learn more about our rich history and follow along with #euromedlab2023 to see what’s next. ➡ diagnostics.roche.com/global/en/article-listing/roche-dia…
-
Roche
@Roche
Access to safe, high-quality diagnostics enables early detection and timely decision making to prevent #cardiovascular disease and its devastating consequences for patients and the health systems. Sign up to learn more: go.roche.com/WorldHeartSummit
-
Roche
@Roche
May is #bladdercancer awareness month, and this year Roche is supporting @WorldBladderCan with its #getchecked awareness campaign. Over half a million people are diagnosed with bladder cancer each, yet most adults are unaware of the signs. Learn more about the symptoms here:
World Bladder Cancer Patient Coalition
@WorldBladderCan
This #bladdercancermonth23 we aim to bring attention to the misrepresentation of #bladdercancer symptoms and encourage people to re-evaluate their symptoms, as what they thought they saw may actually be something different.
Help us 👇 worldbladdercancer.org/wp-content/uploads/2023/05/WBCPC_T…
#getchecked -
Roche
@Roche
Antibodies are highly versatile tools, not only in biology research but also in medicines. Scientists get the starting points from nature and then endow the antibodies with superpowers.👉 www.roche.com/stories/antibody-engineers
-
Roche
@Roche
We are pleased to announce the U.S. FDA has accepted a supplemental Biologics License Application for our bispecific antibody for the treatment of macular edema following retinal vein occlusion (RVO), a leading cause of #visionloss. www.roche.com/media/releases/med-cor-2023-05-09?cid=soadg… $ROG $RHHBY
-
Roche
@Roche
As many treatment decisions are taken based on diagnostic tools, quick and easy access to information is key. Explore the value of diagnostics and digitalisation ➡️ www.roche.com/about/business/diagnostics/value-of-diagnos… #valueofdiagnostics #digitalisation
-
Roche
@Roche
👋Say hello to @IHB_Research! By exploring the potential of human model systems like #organoids and bringing together academia & industry, the Institute of Human Biology aims to speed up drug discovery & development and unlock new research frontiers for the benefit of patients.
Roche
@Roche
Learn more about #organoids: www.roche.com/stories/modeling-the-future
To join #teamihb 🔬and stay up-to-date on our latest research and discoveries🧫, please visit : institutehumanbiology.com -
Roche
@Roche
We are excited to announce the launch of the Institute of Human Biology. The institute brings together scientists from academia and industry to accelerate breakthroughs in R&D, using human model systems.
$RHHBY $ROG #rocheinnovation #science
www.roche.com/media/releases/med-cor-2023-05-04 -
Roche
@Roche
The @WHO resolution “Strengthening diagnostic capacity” presents a unique opportunity to focus on four key aspects impacting health systems. Read more here ➡ www.politico.eu/sponsored-content/putting-health-back-in-… #worldhealthassembly.
-
Roche
@Roche
Life-saving innovation is only meaningful if it reaches those who need it. Without a comprehensive #cvd strategy, patients are left at risk of suffering life-threatening heart conditions, including heart failure. Learn more about the #valueofdiagnostics: www.roche.com/about/business/diagnostics/value-of-diagnos…
-
Roche
@Roche
Scientific exchange is so valuable to the work we do, and it’s always exciting to be able to provide updates on our progress in #ophthalmology. Thank you to all who attended #arvo2023 – the future of vision is looking bright!
-
Roche
@Roche
The CHMP has recommended EU approval of our fixed-duration cancer immunotherapy for patients with relapsed or refractory diffuse large B-cell #lymphoma, one of the most common and aggressive blood cancers among adults. www.roche.com/media/releases/med-cor-2023-04-26b
$RHHBY $ROG #rocheinnovation #science -
Roche
@Roche
We are delighted to announce the results of new phase III data at #arvo2023, on retinal fluid and macular leakage in people with nAMD and DME, two leading causes of #visionloss. www.roche.com/media/releases/med-cor-2023-04-25
$ROG $RHHBY -
Roche
@Roche
Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests. For more details on our performance head here ➡️ go.roche.com/MR2023Q1
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
The past 5-years of advancements of b-cell therapy in #multiplesclerosis have shifted the way in which we manage this progressive condition. Read more on how these advancements are paving the way to improved outcomes for those living with this disease: www.roche.com/stories/multiple-sclerosis-b-cells-research
-
Roche
@Roche
We are excited to share the latest industry-leading research and collaborations with the #neuroscience community at the annual American Academy of Neurology (#aanam) 2023 meeting. Learn more about our work in neuroscience: www.gene.com/media/press-releases/14989/2023-04-24/genent…
-
Roche
@Roche
The recommended @WHO resolution on strengthening diagnostics capacity is a step towards #diagnostics becoming a policy priority. Ann Costello, Global Head of Roche Diagnostics Solutions, talks about the need for more equity in healthcare: go.roche.com/WHOResolutionT
-
Roche
@Roche
The U.S. FDA has granted approval to our new combination treatment for certain types of previously untreated diffuse large B-cell #lymphoma, making it the first therapy in nearly 20 years approved by the FDA for people with this aggressive disease www.roche.com/media/releases/med-cor-2023-04-19
$RHHBY -
Roche
@Roche
Together with the global retina community, we are seeing significant advances in how we tackle #visionloss.
Ahead of #arvo2023, which advancements are you most interested in? Please comment your topic if it is not one of the choices. -
Roche
@Roche
With millions of people living with retinal conditions, scientists are determined to change the status quo. They are tackling the conditions with the goal of hopefully preventing and even reversing, vision loss. 👉 www.roche.com/stories/science-ophthalmology
-
Roche
@Roche
This World Haemophilia Day, @wfhhemophilia is leading the effort to help address and improve access to treatment for bleeding disorders – including haemophilia #whd2023
World Federation of Hemophilia
@wfhemophilia
🥳 Happy #worldhemophiliaday, everyone! 🎈Today, we celebrate our global community and raise awareness for this important cause. Let's spread the word and show our support! #whd2023 #bleedingdisorders Learn more: wfh.org/article/today-is-world-hemophilia-day-2023/
-
Roche
@Roche
HPV self-sampling empowers women to take control of their health privately and conveniently. At #ipvc2023, we’re sharing how this innovative approach is helping underserved women take charge of their health. Learn more 👉 www.roche.com/stories/cervical-cancer-self-sampling
-
Roche
@Roche
#media: At #aacr23, we are pleased to present data showing our cancer immunotherapy combination reduced the risk of cancer returning after surgery in people with a certain type of #livercancer in the Phase III clinical trial.
Read more 👉 www.roche.com/media/releases/med-cor-2023-04-16
$ROG $RHHBY -
Roche
@Roche
We are pleased to share an outline of 30 abstracts to be presented at the upcoming #arvo2023 meeting, demonstrating the strength of our #ophthalmology portfolio. www.roche.com/media/releases/med-cor-2023-04-13
$ROG $RHHBY -
Roche
@Roche
On #worldhealthday & #who75 🎂, discover how our teams & partners tackle current and future #health challenges to help people do more, feel better & live longer. Our goal is to increase #healthcare access for everyone, no matter who and where they are 📷 go.roche.com/AnnualReport
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
At Roche pharma Research & Early Development (pRED), we collaborate with the best in academia and industry, discovering and translating cutting-edge science. Join our Roche Postdoctoral Fellowship Programme and become a part of this.
careers.roche.com/global/en/the-roche-postdoctoral-fellow…
#rocheinnovation -
Roche
@Roche
Science has a history of overlooking women’s stories. Your voice can make a difference. ➡️ go.roche.com/XProjectStories #mystoryforchange #xproject #womenshealth #health #healthcare #genderequality #genderequity
-
Roche
@Roche
Historically, women’s voices have been overlooked in science and healthcare. It’s time for change. ➡️ go.roche.com/XProjectStories #mystoryforchange #xproject #womenshealth #health #healthcare #genderequality #genderequity
-
Roche
@Roche
#media - We are pleased to announce our collaboration with Lilly to enhance early diagnosis of Alzheimer's disease. Learn more: www.roche.com/media/releases/med-cor-2023-03-22 #rog #rhhby #alzheimers
-
Roche
@Roche
We are pleased to present new data from the broadest pivotal clinical trial program in spinal muscular atrophy (SMA) at @MDAorg, as we partner with the community to help improve the lives of people living with #sma.
www.roche.com/media/releases/med-cor-2023-03-20 -
Roche
@Roche
Home to Roche headquarters, Basel is a vibrant hub of innovation.
We are eager to collaborate with like-minded companies, from across the globe, who share our pursuit of advancing cutting-edge science.
Learn more about partnering: www.roche.com/innovation/partnering/pharma
#bioeuropespringThis media couldn't be displayed. See it on the original post. -
Roche
@Roche
On the 3rd day as our new CEO and Chairman, Thomas and Severin meet up with the global patient communities at the #ieepo2023. A day filled with insightful discussions and ideas aimed at creating a more sustainable #healthcare system with #patients at the heart.
Roche
@Roche
One of the highlights of the #ieepo2023? A live Q&A with our new CEO and Chairman. It's a valuable platform for #patients and their representatives from around the globe to connect, exchange #insights, and provide mutual support based on their shared experiences.
-
Roche
@Roche
Today Severin Schwan steps into a Chairman role and passes the CEO baton to Thomas Schinecker. Thomas brings a wealth of experience to lead Roche into the future and advance our mission to help patients live longer, better lives worldwide. Join us in welcoming Thomas and Severin!
Roche
@Roche
As we say farewell to Christoph Franz as the Chairman of the Board, we welcome Severin Schwan on the journey ahead of us 🎉. It's been an immense privilege in having Christoph as part of Roche's continuous purpose - putting patients at the heart of everything we do.
Roche
@Roche
We are grateful for our departing Chairman and excited to welcome our new CEO and Chairman at our Annual General Meeting. With our strong #leadership, dedicated #employees, and trusted #partners, we're ready to navigate the future with confidence. More 👉 go.roche.com/AGMRoche
-
Roche
@Roche
By 2050, over 4.9 billion people could be affected by #brainhealth conditions. The impact on individuals, families, and societies could be significant, as people's ability to feel, think & do is lost.
Join us during #brainawarenessweek to drive action toward a brighter future.This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Collaboration enables us to pursue innovation in diverse ways and tackle the big questions in healthcare. Together with our partners, we will always follow the science.
Learn more about partnering with one of the largest R&D investors in healthcare: www.roche.com/innovation/partnering/pharma -
Roche
@Roche
The U.S. FDA Oncology Drugs Advisory Committee (ODAC) votes in favour of our combination treatment for people with previously untreated diffuse large B-cell lymphoma, an aggressive form of #lymphoma www.roche.com/media/releases/med-cor-2023-03-09
$RHHBY $ROG -
Roche
@Roche
Sharing your story could be the beginning of a new era for #womenshealth to fully #embraceequity and create a more #genderequal world 👉 go.roche.com/XProjectStories #iwd #iwd2023
-
Roche
@Roche
There are over 7000 known rare diseases, with diagnosis taking upwards of 5 years. Roche is working closely with people living with rare diseases to improve access to care, diagnosis and treatment for #rarediseaseday #brighterfutures www.roche.com/solutions/focus-areas/neurology/rare-diseases
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Huntington’s Disease is a rare genetic condition that severely affects a person’s everyday functions. This #rarediseaseday, we want to thank the HD community for their support in helping advance research in this area.
-
Roche
@Roche
Partnerships are a core element of how we innovate. We are committed to co-creating deals tailored to harness the full potential of our shared capabilities.
Hear from James Sabry, to learn what makes Roche the partner of choice for over 250 companies: www.roche.com/innovation/partnering/pharma -
Roche
@Roche
For more than 20 years, we've helped lay the scientific groundwork for personalised #healthcare. Now we're taking it toward a future in which treatments are targeted to an individual’s unique genetic profile. Discover our purpose-led journey here ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
#media - We are pleased to announce the launch of two new antibodies to identify key clinical mutations in patients with #brain cancer, helping clinicians to quickly determine the optimum treatment path. Learn more: www.roche.com/media/releases/med-cor-2023-02-23 #braintumour $ROG $RHHBY
-
Roche
@Roche
Thomas’s passion for #sustainability has been his driving force for 30 years. He helps ensure that our climate mitigation #strategy is driving Roche toward the goal of reducing our greenhouse gas emissions to zero. Discover our purpose-led journey here ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
“I dream of applying organoid technologies everywhere along the drug development pipeline at pRED.” Says Hans Clevers, our own head of pRED, in this new @Nature article.
www.nature.com/articles/d41573-023-00030-y
Roche
@Roche
Organoids have the potential to take the complexities of drug development to the next level and improve the odds of success.
Roche
@Roche
At Roche pRED we are strengthening the role of organoids as a new human model system in early pharma research to work towards the ambitious goal to accelerate drug discovery and development.
www.roche.com/stories/organoids-in-research-technologies/ -
Roche
@Roche
We have long been working to improve #oncology care. Our recent #partnership in Ghana is one of the examples of the power of #partnerships that directly benefit patients. Learn more about our journey in 2022 to help break down barriers to #healthcare ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
Take a journey through our business year in 2022 and discover how the #technology called comprehensive genomic profiling brings new hope in the fight against rare #cancers to patients like Susanne ➡️ go.roche.com/AnnualReport #cancer #genes #health
-
Roche
@Roche
“Everyone deserves access to the best #cancer diagnostic tools and therapies, so they can have more time with the people they love,” says Hiro whose work has already impacted the lives of millions of patients. Learn about our purpose-led journey here ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
Changing the way women with #diabetes are treated starts with you! 💪 Share your story with us and let's #closethegaps in healthcare together! ➡️ go.roche.com/XProjectStories #mystoryforchange #xproject #diabetescare #diabetesawareness
-
Roche
@Roche
Today we announce new data from two phase III studies evaluating our bispecific antibody in people living with retinal vein occlusion (RVO). Both clinical trials met their primary endpoints.
#rocheinnovation
www.roche.com/media/releases/med-cor-2023-02-10
$RHHBY $ROG -
Roche
@Roche
Frankline received treatment for her breast #cancer through the first national access programme in Kenya - our latest collaboration between @MOH_Kenya and @nhifkenya. Learn more about our journey in 2022 to help break down barriers to #healthcare ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
We extend our heartfelt condolences to those impacted by the tragic earthquake affecting Türkiye and Syria. All of our employees are safe and accounted for. You can read more about how we are supporting colleagues and local relief efforts in our statement: www.roche.com/media/releases/med-cor-2023-02-09
-
Roche
@Roche
We are at a pivotal moment in healthcare history, but one thing has remained constant – the power of partnerships.
James Sabry, Head of Pharma Partnering, explains how our 125-year scientific history makes us a resilient partner in times of instability: www.linkedin.com/pulse/partnering-2023-finding-stability-… -
Roche
@Roche
Uncover insights into our work in 2022 focused on life-changing #innovation and our combined strengths in #diagnostics and #pharmaceuticals 👇
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Dr Altamirano has played a key role in advising the @ministeriosalud in an important step towards eradicating cervical #cancer in the country. Discover more insights into our purpose-led journey in 2022 to help break down barriers to #healthcare ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
We are pleased to announce positive data from our global phase III programme in paroxysmal nocturnal haemoglobinuria (#pnh), a rare life-threatening blood condition.
Learn more: www.roche.com/media/releases/med-cor-2023-02-07 -
Roche
@Roche
Uncover insights into our work in 2022 focusing on life-changing #innovation and our combined strengths in #diagnostics and #pharmaceuticals ➡️ go.roche.com/AnnualReport #health #healthcare
-
Roche
@Roche
Margareth is one of the first nurses enrolled in Indonesia’s new #oncology nurse training program supported by us. She will be among the first ones in her province, alleviating an overburdened #healthcare system. See more insights into our business year ➡️ go.roche.com/AnnualReport
-
Roche
@Roche
Take a journey through our business year in 2022 and uncover how our teams brought change to millions of patients around the world ➡️ go.roche.com/AnnualReport
#health #healthcare #innovation -
Roche
@Roche
By putting science at the heart of Roche, our ambition is to help people do more, feel better, live longer. Learn more about how our teams made an impact in 2022 ➡️ go.roche.com/AnnualReport
$ROG $RHHBY -
Roche
@Roche
Discover how our teams made an impact in 2022 while tackling some of the world’s biggest health challenges. For insights into our purpose-led journey head here ➡️ go.roche.com/AnnualReportMR $ROG $RHHBY
-
Roche
@Roche
Science has a history of overlooking women’s #health. Your voice can make a difference. Help us drive meaningful change in #womenshealth by sharing your story ➡️ go.roche.com/XProjectStories
#mystoryforchange #xproject #healthcare #genderequality #genderequity -
Roche
@Roche
We are pleased to announce that the EU has approved the label expansion of our medicine to include moderate #haemophilia A without inhibitors. Learn more: www.roche.com/media/releases/med-cor-2023-02-01
-
Roche
@Roche
#media - we are pleased to announce the launch of our new PCR test for researchers that detects and differentiates the latest #covid19 variant of concern, XBB 1.5. www.roche.com/media/releases/med-cor-2023-01-26 $ROG $RHHBY
-
Roche
@Roche
We at Roche are very proud of @HansClevers, our Head of Pharma Research and Early Development, to receive the 14th Weinman Award for his groundbreaking work on #organoids.
This prize also highlights the importance of organoids for research and development.
#rocheinnovation
University of Hawaii Cancer Center
@UHCancerCenter
International leaders in various fields of cancer research, science, & medicine will convene at the 14th Annual Weinman Symposium this Wed-Fri at the UH Cancer Center. Renowned Dutch geneticist, @HansClevers, will be honored this year. More about Clevers: go.hawaii.edu/kiG
-
Roche
@Roche
#media: We are pleased to announce that for the first time in a Phase III clinical trial, our cancer immunotherapy reduced the risk of cancer returning in people with certain types of early-stage #livercancer
Read more 👉 www.roche.com/media/releases/med-cor-2023-01-19
$ROG $RHHBY -
Roche
@Roche
Your story has the power to ignite the spark and bring change to #womenshealth. With #xproject, we are determined to bring your voice to the forefront. Join us on our journey to close the gaps in women’s #health 👉 go.roche.com/XProject_SubmissionHub #mystoryforchange #healthcare
-
Roche
@Roche
Digital technologies are revolutionizing healthcare for women. From FemTech, which collects more data on women’s health, to AI diagnostic tools for breast cancer, new technologies are paving the way to advance women’s health. #xproject #makethedifference go.roche.com/technology-for-womens-health
-
Roche
@Roche
Access to care still prevents some women from ever being screened for #cervicalcancer. Learn more about a new #hpv self-collection option that offers equivalent clinical information about risk for the disease. www.roche.com/stories/cervical-cancer-self-sampling
#valueofdiagnostics -
Roche
@Roche
No woman should die from #cervicalcancer. Which of the following myths about #hpv and cervical cancer have you heard before?
Roche
@Roche
Are misinformation and myths stopping you from being screened for cervical health? Learn more: go.roche.com/CerCancerAM #cervicalcancer
-
Roche
@Roche
We are pleased to announce that the @EMA_News has approved our single-dose influenza antiviral in children aged one year and above to treat uncomplicated #influenza and for post-exposure prophylaxis of influenza. www.roche.com/media/releases/med-cor-2023-01-12 $RHHBY $ROG #rocheinnovation #science
-
Roche
@Roche
“There needs to be a fundamental shift in #healthcare and working together in a spirit of partnership is essential,” says Roche Chairman Christoph Franz
Learn more about our contribution to the transformation of healthcare ➡️ go.roche.com/HealthcareAccess #wef23 -
Roche
@Roche
Only 25% of the senior roles in the health sector are held by women. Without the voices of women in senior positions, women’s needs and experiences are swept under the rug. It’s time to change the facts and #makethedifference. Join the journey. #xproject www.roche.com/xproject/xstories/women-in-leadership
-
Roche
@Roche
We are pleased that the U.S. FDA has accepted our Biologics License Application, under priority review, for new investigational immunotherapy in relapsed or refractory large B-cell #lymphoma www.roche.com/media/releases/med-cor-2023-01-06
$RHHBY $ROG -
Roche
@Roche
It's time to put women's health firmly in the spotlight. It's time for change. Join #xproject 👉 go.roche.com/notsofunfacts
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Listen to our podcast where we discuss why partnerships that support mentorship, skills development and diagnostics capacity are vital in empowering the next generation of lab technicians to end #aids. www.roche.com/stories/fighting-pandemics #hivawareness #red #valueofdiagnostics
-
Roche
@Roche
We are pleased that the U.S. FDA has approved our first-in-class cancer immunotherapy for people with relapsed or refractory follicular lymphoma who have had limited treatment options until now.
www.roche.com/media/releases/med-cor-2022-12-23 $RHHBY $ROG #rocheinnovation #science -
Roche
@Roche
We're delighted that the @US_FDA
has approved our medicine to treat hospitalised patients with #covid19, providing an important option to continue to address the pandemic. www.roche.com/media/releases/med-cor-2022-12-21 $ROG $RHHBY -
Roche
@Roche
Listen to our podcast where we discuss how empowering laboratory workers to fight pandemics through improved access to #hiv diagnostics can help reach an AIDS-free generation by 2030.
#hivawareness #aids #worldaidsday #valueofdiagnostics
👉 www.roche.com/stories/fighting-pandemics -
Roche
@Roche
Did you know that our immune system is a complex and finely tuned fighting force, primed to recognise pathological cells or microorganisms in our body that don’t belong and destroy them?
Post not available here, view on X
Roche
@Roche
Learn more about our discoveries: www.roche.com/stories/immune-power
Roche
@Roche
We hope this #tweetorial was insightful.
-
Roche
@Roche
The CHMP has recommended expanding the indication of our haemophilia treatment in the EU to include people with moderate #haemophilia A. Learn more: www.roche.com/media/releases/med-cor-2022-12-16
-
Roche
@Roche
#cancercare is so much more than selecting a treatment. Alba, an oncology #nurse, shares how she supports patients day to day.
Check out her full video here: youtu.be/ljQg0IpQUnE -
Roche
@Roche
Pioneering data solutions can detect the risk of disease, predict how a disease may progress and enable the right treatment decision at the outset. See how we’re applying some of these tools to our therapeutic research. ⬇️
www.roche.com/topic/personalised-healthcare
#personalisedhealthcare -
Roche
@Roche
#media - We are pleased to announce U.S. focused collaboration with @pfizer to raise awareness on #covid19 testing, treatment options, symptoms, and the high-risk factors that can increase the chance of progressing to severe illness. Read more: www.roche.com/media/releases/med-cor-2022-12-14 $ROG $RHHBY
-
Roche
@Roche
Over the weekend at #ash22 we presented data demonstrating the potential benefit of a new type of cancer immunotherapy in improving outcomes for difficult-to-treat #lymphomas www.roche.com/media/releases/med-cor-2022-12-12c $RHHBY $ROG #rocheinnovation #lymsm
-
Roche
@Roche
We are pleased to present updated results in diffuse large B-cell lymphoma at #ash22, an area where there has been little progress in the first-line setting for the last 20 years www.roche.com/media/releases/med-cor-2022-12-12b $RHHBY $ROG #rocheinnovation #lymsm
-
Roche
@Roche
Starting #cancer treatment can be a daunting experience, and #nurses like Alba play a crucial role in ensuring patients feel as relaxed as possible.
Check out Alba’s full video here: youtu.be/ljQg0IpQUnE -
Roche
@Roche
We’re pleased to present interim results at #ash22, from a phase III study in infants with severe #haemophilia A without factor VIII inhibitors www.roche.com/media/releases/med-cor-2022-12-11b $RHHBY $ROG #rocheinnovation
-
Roche
@Roche
The first phase III results from our study in #pnh, an ultra-rare, life-threatening disease of the blood are being presented at #ash22 www.roche.com/media/releases/med-cor-2022-12-11 $RHHBY $ROG #rocheinnovation
-
Roche
@Roche
A long history of women's underrepresentation in science have engendered systemic inequities and challenges in healthcare and research. #xproject is our commitment to helping change the facts and close the gap in women’s health. go.roche.com/notsofunfacts
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media - We are pleased to announce #alzheimer’s disease CSF assays receive @FDA clearance, supporting more accurate and timely diagnosis. Learn more: www.roche.com/media/releases/med-cor-2022-12-08 #rog #rhhby
-
Roche
@Roche
Together with our partner @RED, we celebrate people like Cynthia Banda, Laboratory Technician at Churches Health Association of Zambia (CHAZ), dedicated to making a difference in the fight against #hiv. Listen to our podcast: www.roche.com/stories/fighting-pandemics
#aids #valueofdiagnostics -
Roche
@Roche
Lack of women’s representation in medical research means there is insufficient data to create solutions targeted to women’s needs, exacerbating disparities in healthcare. Learn more about closing the gaps in women’s health to #makethedifference. #xproject go.roche.com/femalescientists
-
Roche
@Roche
Women’s health has been traditionally underfunded. @SpringboardEnt with CEO Natalie Buford Young have made it their mission to close the gaps in funding for women’s health. Tune in to our podcast to learn more. #xproject
go.roche.com/business-case-wh -
Roche
@Roche
We fully endorse World Antimicrobial Awareness Week!
By joining forces, we can improve awareness and understanding of AMR and encourage best practices. Fighting back together.
👉 celebratelife.roche.com/explore/science/neuroscience-amr/
#science #strongertogether #rocheinnovation -
Roche
@Roche
We are proud to share that @HansClevers, our Head of pRED, was listed for the 8th time in @Clarivate's #highlycited2022 Researchers list. This shows his consistent influence in fields such as Molecular Biology and Genetics.
👉 clarivate.com/news/clarivate-names-worlds-influential-res…
#rocheinnovation -
Roche
@Roche
This is how we advance digital solutions helping to enhance the patient journey to the finish line: Our own Julia Eaton lays out our unique approach to identifying and addressing gaps in care so we can deliver what patients need most.
-
Roche
@Roche
Investing in health pays off for people and economies. Alan Donnelly of @G20Partnership points out, “The cost of #covid19 was trillions because we failed to invest in pandemic preparedness. Now, looking at the trends for #cancer…we must invest.” #londonglobalcancerweek @LGCW2022
-
Roche
@Roche
At #londonglobalcancerweek, @dinamired shared her call to prioritise #cancer, “Countries have been so overwhelmed for so long in tackling cancer, they shied away from it. But imagine if they had started taking small steps 10 years ago? We can’t ignore the disease of the century.”
-
Roche
@Roche
JOIN US: Join our #londonglobalcancerweek event with @ChathamHouse to hear from experts on policy solutions to increase access to #cancer screening , diagnostics, treatment & care in low- and middle-income countries. Tune in to the livestream: us06web.zoom.us/j/86133439691
-
Roche
@Roche
#media - First #monkeypox test granted @US_FDA EUA following evaluation in actual patient samples. Accurate & reliable high-throughout solution enables rapid results and allows access to appropriate treatment as soon as possible. Learn more: www.roche.com/media/releases/med-cor-2022-11-16 $ROG $RHHBY
-
Roche
@Roche
Today, we're looking forward to co-hosting a #lgcw session with @ChathamHouse about the role universal health coverage can play in improving access to cancer care for all. Join the live discussion at 12:00 GMT: www.eventbrite.com/e/reducing-inequities-in-cancer-care-i… @LGCW2022
-
Roche
@Roche
By 2030, @IARCWHO data show ¾ of cancer deaths will occur in #lmics. Join us on 16 Nov for an event co-hosted with @ChathamHouse, “Reducing Inequities in Cancer Care,” to learn how universal health coverage can help to close the cancer care gap: www.eventbrite.com/e/reducing-inequities-in-cancer-care-i… @LGCW2022
-
Roche
@Roche
#media: Findings from two of our Phase III clinical trials in #alzheimersdisease are now available. Although the trials did not meet their endpoints, we remain committed to making a meaningful difference to all those affected by the disease. Read more: www.roche.com/media/releases/med-cor-2022-11-14
-
Roche
@Roche
The gender data gap has led to a lack of awareness of the gender differences in many conditions, including heart attack. Through our #xproject, we aim to address this disparity and help transform the future of women’s health. Join us. #makethedifference go.roche.com/GenderDataBias
-
Roche
@Roche
This new white paper from @economistimpact offers key recommendations for meeting the growing global demand for eye care: insights.economistenterprise.com
What challenge should be addressed first to best support your #vision? #eyecare -
Roche
@Roche
Many women with cancer, like Marie, face barriers when it comes to fertility preservation. Discover how we’re working with partners to close the gap and ensure every woman with cancer knows her options and is empowered to make the best decision. #xproject go.roche.com/fertilitypreservation
-
Roche
@Roche
How do we ensure data is leveraged effectively – and transparently – in our work to advance #personalisedhealthcare? Digital health leader, Helena Waahlin, explains important considerations when using data-driven digital solutions to improve patient care ⬇️
-
Roche reposted
Lung Cancer Europe
@LungCancerEu
If you have one or more of these symptoms, please don't wait. #getchecked today!
Visit getchecked.eu/symptoms/ to learn more.
This campaign is endorsed by:
@EuroRespSoc @EuropeanLung @eupatientsforum
#getcheckedeurope #lungcancereurope #lcsm #lungcancerawarenessmonth #lcam -
Roche reposted
Rebecca Akufo-Addo
@RAkufoAddo
The Rebecca Foundation, in collaboration with Roche and The Ghana Health Service, has trained 30 health staff in Akim Oda in the Birim Central District to build their capacity to screen women for breast and cervical cancers and treat early-stage cervical cancer.
-
Roche
@Roche
Digital health advancements can increase accessibility and enable data-driven treatment decisions. Our own Leslie Fendt explains how remote monitoring solutions could help patients, providers, and healthcare systems alike in improving #personalisedhealthcare.
Roche
@Roche
Would you use remote monitoring tools to track and personalize your health?⬇
-
Roche
@Roche
A huge thank you to all those who attended the first #oncologycollective meeting! United by our passion for delivering progress for patients, we look forward to continuing this dialogue to redefine the future of cancer care. #rocheinnovation
-
Roche
@Roche
The explosion of healthcare enables us to unlock new breakthroughs in #personalised healthcare. Feifei Wei, an integrated solutions leader, discusses one way we’re using data to derive imaging algorithms that can help physicians assess tumour burden more quickly.
-
Roche
@Roche
At #oncologycollective we are joining forces with experts across the field, to tackle the next big questions in cancer research and pave the way for meaningful advances in patient care. #rocheinnovation
-
Roche
@Roche
To tackle the staggering complexity of cancer we need to think holistically. #oncologycollective brings together experts across the field to identify the next key questions in cancer research and collaborate to accelerate progress in patient care. #rocheinnovation
-
Roche
@Roche
Over 50 abstracts at #ash2022 feature our broad haematology portfolio and pipeline, reinforcing our commitment to address the needs of people with blood disorders including #haemophiliaa, #lymphoma and #pnh www.roche.com/media/releases/med-cor-2022-11-03
$RHHBY $ROG #rocheinnovation #media -
Roche
@Roche
The stigma and lack of awareness surrounding lung cancer leads to significant gender disparities in lung cancer incidence. #xproject aims to #makethedifference in women’s health. Visit & learn more. go.roche.com/notsofunfacts
-
Roche
@Roche
“We are sorry, but there’s really nothing we can do.” Danielle recalls the days after Bonnie, her mother, was first diagnosed with lung cancer.
To mark the start of #lungcancerawarenessmonth, hear their inspiring story: www.roche.com/stories/bonnie-addario-patient-to-lung-canc… @GO2Foundation -
Roche
@Roche
We are honored to be one of the world’s top 20 #biopharma employers in the @ScienceCareers 2022 Top Employers Survey.
What qualities do our scientists value most while working for Roche? Find more in the link: www.science.org/content/article/2022-s-top-employers-prov…
#sctopemployer
#rocheinnovation -
Roche
@Roche
Hear from Karolina as she shares how she manages her #multiplesclerosis on a daily basis while being a mother to her children: youtu.be/4jHGdHJWyvA #mymsportrait #ectrims2022 #diseaseprogression
Roche
@Roche
For women living with #multiplesclerosis, what is the biggest concern around family planning?
-
Roche
@Roche
For women living with #multiplesclerosis, what is the biggest concern around family planning?
-
Roche
@Roche
By 2050 it is predicted that the number of people experiencing vision loss will rise to 1.8bn. Read the report by @EconomistImpact to understand the economic and social impact of vision loss and what this means for the future of eye care. impact.economist.com/projects/vision-for-change/infograph… #rocheinnovation
Economist Enterprise
@econ_enterprise
In developed countries, retinal diseases, including age-related macular degeneration and diabetic retinopathy, are the most common cause of irreversible #blindness presenting a growing public health issue. Learn more: econ.st/3DjIOOx
Supported by @Roche -
Roche
@Roche
At #wcc2022, VP and Head of Global Access Policy & Advocacy Tamara Schudel spoke about why investing in health is important for the future. To determine what investments are effective, we worked with @IQVIA to identify innovative funding trends. Read more: www.iqvia.com/-/media/iqvia/pdfs/asia-pacific/white-paper…
-
Roche
@Roche
As #breastcancerawarenessmonth has drawn to a close, we asked our contributors what #bcam means to them. Swipe below to see why it’s important to look beyond the medicines and focus on patient-centric care throughout the entire #breastcancer treatment pathway
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Brian, Patrick, Graham and Karolina share their personal experiences of living with #multiplesclerosis, and how they manage their condition every day to continue pursuing what’s important to them. Read more: www.roche.com/stories/portraits-of-ms #mymsportrait #ectrims2022 #diseaseprogression
-
Roche reposted
World Hepatitis Alliance
@Hep_Alliance
#livercancer cases are on the rise, but early diagnosis of #hepatitis can help prevent it.
Several people with hepatitis are asymptomatic & don't know they're infected. There are many barriers to diagnosis. We can’t wait for increased access to #testing!
#lcam #hepcantwait -
Roche
@Roche
Today we announced topline results from our two phase III studies evaluating our novel bispecific antibody for people living with branch and central retinal vein occlusion affecting 28 million people globally. www.roche.com/media/releases/med-cor-2022-10-27?cid=soadx… $RHHBY $ROG
-
Roche
@Roche
We’re proud to announce new data at #ectrims2022 showing important clinical and economic outcomes of early treatment in relapse-remitting #multiplesclerosis, pregnancy outcomes from 2,000+ women, and 9-year safety data: www.roche.com/media/releases/med-cor-2022-10-26 $RHHBY $ROG
-
Roche
@Roche
We gave the world a glimpse into what makes us proudly Roche. Check out our collection of moments that made us. 👉 go.roche.com/125Microsite
#roche125 #celebratelife -
Roche
@Roche
A new report from @EconomistImpact brings together #data from different countries and multiple #neurological disorders to help us understand how we can reduce their impact, globally.
Interested in the report findings? Visit impact.economist.com/perspectives/healthcare/mitigating-g…
#neuroscience -
Roche
@Roche
#cervicalcancer is one of the most common cancers for women worldwide, despite it being preventable and treatable if detected early and managed effectively. Last week, at #wcc2022 we brought together experts to discuss the importance of early, accurate screening and diagnosis.
-
Roche
@Roche
The IEEPO 2022 'Uniting for Change event' taught us so much. We learned about how we can Humanise Healthcare in the context of Conflict, Climate and Covid. To find out more about the event, visit: www.ieepo.com/en/events/crisis/about-event.html
-
Roche
@Roche
#media – We are pleased to announce FDA clearance for one of the first #covid19 PCR tests performed on high-throughput automated platform – ensuring access to timely, reliable and accurate testing beyond EUA period. Learn more: www.roche.com/media/releases/med-cor-2022-10-24 $ROG $RHHBY
-
Roche
@Roche
For women living with #multiplesclerosis, it can be difficult to understand how MS may impact family planning. Listen to Karolina’s story as she shares how she manages her condition while following her innate instinct of becoming a mother: youtu.be/4jHGdHJWyvA #mymsportrait
-
Roche
@Roche
The numbers don’t lie: gender inequities in healthcare are reflected in the frequent discrimation in research funding. It’s time to change the facts. Join #xproject and help us shape the future of women’s health. #makethedifference go.roche.com/notsofunfacts
-
Roche
@Roche
Differences in skin tones continue to influence diagnosis and treatment to this day. We push for inclusivity in all aspects of our work and address inequities by working towards greater diversity in healthcare.
#diversityandinclusion #clinicaltrials #equity -
Roche
@Roche
Successful partnerships need to be built around clear outcomes and expectations. Watch our panel at the
@WorldHealthSmt to learn more about how we can accelerate progress towards Universal Health Coverage. www.youtube.com/clip/UgkxrGVxIq5r8Y4FHo7xcYbDbkRZkhd-qjIe -
Roche
@Roche
Partnerships built on a foundation of trust are the key to overcoming global health challenges. A healthier future will require all sectors to collaborate and work together to equitably increase access to healthcare. Learn more: www.youtube.com/clip/Ugkxg9KzE19cYyNWpIOjubjBZ4El6eUYCU0F… #whs2022 #wcc2022
-
Roche
@Roche
We are proud to announce new data to be presented at #ectrims2022 on disease activity and progression in patients with early-stage relapsing remitting #multiplesclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: www.roche.com/media/releases/med-cor-2022-10-19 $RHHBY $ROG
-
Roche
@Roche
🧠How can participants and their study partners involved in #alzheimersdisease clinical trials help improve the experience for others?
📝Our new report, developed with our partners and launched at #32aec with @AlzheimerEurope, explores the question ⬇️
www.roche.com/stories/designing-clinical-trials-alzheimer… -
Roche reposted
European Liver Patients' Association
@EuropeLiver
Patients should be at the heart of all the decisions about them. #livercancerawarenessmonth @EU_Health @WHO_Europe @hans_kluge @SKyriakidesEU @dice_europe @Marko_Korenjak @MKDmilanM @AleksanderKrag @EASLnews @EASLedu @EASLEUAffairs @ILCAnews @FattyLiverA @LiverSaver #livertwitter
-
Roche reposted
Coalition for Global Hepatitis Elimination
@GlobalHep
October is #livercancerawarenessmonth! We are calling on the world to take action against #viralhepatitis to prevent #livercancer and save lives. #lcam #hepb #hepc
-
Roche
@Roche
Our CEO Severin Schwan on the results of the first nine months of 2022 📈
👉Read the full release here: www.roche.com/media/releases/med-cor-2022-10-18
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
📢 Roche records solid results for the first nine months of 2022
👉 Read the full media release here: www.roche.com/media/releases/med-cor-2022-10-18
$ROG $RHHBY #rochefinancialresults -
Roche
@Roche
With only one neurologist per million people in LMICs, addressing this limited access to care is essential to mitigating the impact of neurological conditions in the most prevalent regions. Find out more from the new report by @EconomistImpact econ.st/3yBRqyL
Economist Enterprise
@econ_enterprise
From economic prioritisation to policymaking, neurological disorders must be made a priority. Learn what impact the cost of #neurologicaldisorders has globally, and where the biggest opportunities for mitigation lie: econ.st/3yBRqyL
Sponsored by @Roche -
Roche
@Roche
The International Experience Exchange with Patient Organisation’s (IEEPO) infographic is live!
The goal is to Humanise Healthcare whether you’re a policymaker, a healthcare worker, or a patient organization member!
Check out the infographic: www.ieepo.com/en/ieepo-position-paper/position-paper-info… -
Roche
@Roche
Neuromyelitis Optica spectrum disorder is often compared with multiple sclerosis. Whilst there are similarities, there are important differences.
Watch the animations here: www.youtube.com/watch?v=Hx-jSi-ujsI
#ectrims2022 #nmosd #multiplesclerosis -
Roche
@Roche
We are proud to support the @IAPB this #worldsightday and see over 5 million people prioritize eye health #loveyoureyes
IAPB
@IAPB1
Together, we DID IT! 🎉
Five million people have pledged to #loveyoureyes this #worldsightday. -
Roche
@Roche
50% of the total global cost of neurological
disorders is indirect. A new report from
@EconomistImpact is looking to address this
by helping us understand the global burden of
neurological disorders. Interested in the report findings? insights.economistenterprise.com/perspective s/healthcare…
#neuroscience
Economist Enterprise
@econ_enterprise
From economic prioritisation to policymaking, neurological disorders must be made a priority. Learn what impact the cost of #neurologicaldisorders has globally, and where the biggest opportunities for mitigation lie: econ.st/3yBRqyL
Sponsored by @Roche -
Roche
@Roche
Today is World Sight Day, and with over 1 billion people still without access to eye care, we support the @IAPB1 in their mission to bring attention to this global health issue: www.iapb.org/world-sight-day/about-world-sight-day/?cid=s…
#loveyoureyes #transforminglives -
Roche
@Roche
Lung cancer research has made a major difference for patients. It is vital that this progress continues.
What do you think are the biggest advances needed to redefine lung cancer? -
Roche
@Roche
We are delighted to present new #spinalmuscularatrophy (#sma) data at this year’s @WorldMuscleSoc congress, showcasing our ongoing efforts in advancing therapies for a broad population of those living with SMA. Read more here 👉 www.roche.com/media/releases/med-cor-2022-10-12
#wms2022 -
Roche
@Roche
Great to see some familiar faces passing the glasses to support raising eye health as an issue on the global agenda. 💙
IAPB
@IAPB1
Eye care that is available, accessible and affordable for all is a global issue that requires a unified global response!
#passiton... 👓
#loveyoureyes❤️ iapb.org/WSD2022
#worldsightday #2030insight -
Roche reposted
IAPB
@IAPB1
Eye care that is available, accessible and affordable for all is a global issue that requires a unified global response!
#passiton... 👓
#loveyoureyes❤️ iapb.org/WSD2022
#worldsightday #2030insight -
Roche
@Roche
This year, #rochepressday will be focused on women's health and its link to equality. This is our commitment to the future, to the present, and to our memory. This November 3, #letsmakehistory.
More information at www.rochepressday.com
#womenhealthandequality -
Roche
@Roche
#media - We are pleased to launch a test to identify PRAME protein expression in patients that may have #melanoma, helping improve diagnostic decisions. Learn more: www.roche.com/media/releases/med-cor-2022-10-11 #skincancer $ROG $RHHBY
-
Roche
@Roche
In order to realize the benefit of innovative, targeted treatments existing healthcare systems must evolve. Through multi-sector collaborations we’re addressing local barriers and laying the groundwork to accelerate personalised care worldwide. Learn more: www.roche.com/stories/building-bridges-in-personalised-he…
-
Roche
@Roche
What is the #ieepopositionpaper? The paper aims to improve healthcare systems around the world. At the ❤️ of the paper is a call to 'humanise healthcare'- This means re-building healthcare systems around the needs of patients & their communities
Let’s find out more #tweetorialPost not available here, view on X
Roche
@Roche
The #ieepopositionpaper on #humanisinghealthcare, available in 7 languages & composed of 5 key chapters, is based on global community demand & call to action to empower change & transformation of healthcare systems🌍
Keep reading to learn more about each chapter...
Roche
@Roche
Imagine a healthcare system where compassion & care are valued equally, Chapter 1 of the #ieepopositionpaper focuses on putting people at the 💙 of healthcare. Healthcare professionals need to “see” and treat the patient 👀 not just the illness...
www.ieepo.com/en/ieepo-position-paper/chapter-one.htmlPost not available here, view on X
Roche
@Roche
Equip yourself & become a champion for #humanisinghealthcare by using the Position Paper toolkit! The toolkit contains key slides, lay language summaries, a policy backgrounder & relevant case studies📚 Visit www.ieepo.com/en/ieepo-position-paper/toolkit.html to download the toolkit & stay updated🌟
Roche
@Roche
To round off our #tweetorial we want to know which #ieepoposition Paper chapter resonates with you the most? Feel free to reply to this tweet and let us know why 💬 #ieepo2022 #humanisinghealthcare
-
Roche
@Roche
What do you consider a best practice for strategic partnerships to support universal health coverage implementation?
-
Roche
@Roche
This World Mental Health Day, let us help you prioritise your mental wellbeing. Self care is health care.
👉 careers.roche.com/global/en/safety-health-and-wellbeing
#mentalhealth #wmhd #endthestigma -
Roche
@Roche
R&D teams at Roche and @Genentech are collaborating with @RecursionPharma to explore uncharted territories of cell biology and drug discovery. Learn how the partnership leverages large-scale data using advanced computational methods 👇🙌🔬 www.roche.com/stories/recursion
-
Roche
@Roche
Research suggests that by thinking differently, we can complement existing therapies for a wide range of diseases. A great collaboration advances the understanding of how tissue cells contribute to immune responses in multiple diseases. Learn more: www.roche.com/stories/following-the-fibroblasts
-
Roche
@Roche
Well-designed universal health coverage programmes can reduce health inequities and expand access to care, including for breast and cervical cancers. Join us at #whs2022 to discuss why #uhc is a prerequisite to reducing the global cancer burden. www.worldhealthsummit.org/Program/WHS2022
-
Roche
@Roche
How can we address inequities in women’s health from “inside the box”? Click here to learn more about how we are taking action at this year’s 2022 InCube Challenge. 👉 www.linkedin.com/pulse/thinking-inside-box-close-gender-d…
#rocheinnolab #xproject #incube #eth -
Roche
@Roche
It is the mission of @cancertrials_ie to develop and provide access to the most efficient and effective cancer clinical trials network, which includes research units, clinical and operational leadership, and enabling services.
#sixdegreesofinnovation #innovateforlife
Roche
@Roche
98% of all cancer treating specialists in Ireland are members of @cancertrials_ie. They support and oversee the running of over 100 trials involving thousands of patients.
Since its establishment in 1996, more than 15,000 patients have participated in over 350 cancer trials.This media couldn't be displayed. See it on the original post. -
Roche
@Roche
98% of all cancer treating specialists in Ireland are members of @cancertrials_ie. They support and oversee the running of over 100 trials involving thousands of patients.
Since its establishment in 1996, more than 15,000 patients have participated in over 350 cancer trials.This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Celebrating 20 years of being stronger together! Find out more about Chugai as well as other Innovation Engines using the link in our bio : www.roche.com/innovation/structure/
-
Roche
@Roche
We are pleased to present data at @WorldMuscleSoc next week from across our growing neuromuscular portfolio. Read more here 👉 www.roche.com/media/releases/med-cor-2022-10-05
-
Roche
@Roche
The #ieepo2022 ‘Uniting for Change’ event is about the need to Humanise Healthcare. It's an opportunity for exchange, where patient representatives can come together for support, growth and development. 🖱️ here for agenda www.ieepo.com/en/events/crisis/about-event.html
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
#media - We are pleased to announce FDA approval for first companion #diagnostic to identify metastatic breast cancer patients with low #her2 expression eligible for a targeted treatment option. Learn more: www.roche.com/media/releases/med-cor-2022-10-04
#precisionmedicine $ROG $RHHBY -
Roche
@Roche
Hear from Graham as he shares more on the steps he’s taking now to better manage his #multiplesclerosis for the future: www.youtube.com/watch?v=01PCwcejO7k #mymsportrait #diseaseprogression
Roche
@Roche
For people living with #multiplesclerosis, what is your biggest concern for the future?
-
Roche
@Roche
For people living with #multiplesclerosis, what is your biggest concern for the future?
-
Roche
@Roche
Health equity is a major problem in healthcare research – and stakeholders across the ecosystem, from regulators to patients, are demanding better representation. Listen to our two-episode #podcast special on inclusive research, out now: www.celebratelife.roche.com/participate/life-talks-san-fr… #rochelifetalks
-
Roche
@Roche
As this #pfmonth ends, we hope to have contributed to supporting people living with PF to improve their lives.
EU-PFF
@EU_IPFF
Today marks the last day of #pfmonth and the #breathinglife campaign! Use the resources, consultation guides and videos on eu-ipff.org and of our partners to educate fellow patients and citizens about #pulmonaryfibrosis - it could be lifesaving. #curepf
-
Roche
@Roche
#dyk that the most common cardiac arrhythmia, atrial fibrillation, leads to a five-fold higher risk of having a stroke? Better prediction can help reduce this risk 👉 www.roche.com/stories/atrial-fibrillation-management-in-c…
#worldheartday2022 #hearthealth #cardiology -
Roche
@Roche
#dyk that cardiovascular disease is the number one cause of mortality, accounting for more than 30% of all global deaths? 👉 www.roche.com/solutions/focus-areas/cardiometabolic/cardi…
#worldheartday2022 #hearthealth #cardiology -
Roche
@Roche
For Helen, Bernd and Stefan, living with #alzheimersdisease does not define who they are.
Watch our #whatmakesyouyou series, in partnership with @AlzheimerEurope this #worldalzmonth to find out more. www.youtube.com/watch?v=GN5Zg03aEzk&list=PLmXzuVn0p6GCo6j… #knowalzheimers -
Roche
@Roche
For Helen, Bernd and Stefan, living with #alzheimersdisease does not define who they are.
Watch our What Makes You, You series this #worldalzmonth to find out more.
www.youtube.com/playlist?list=PLmXzuVn0p6GCo6jAxI4P584cyz…
#knowalzheimers #whatmakesyouyou -
Roche
@Roche
As we age, health becomes more important. Hear Graham’s story this #healthyagingmonth as he strives to remain active and mindful in managing his #multiplesclerosis after his diagnosis at 55 years old www.youtube.com/watch?v=01PCwcejO7k
#mymsportrait -
Roche
@Roche
Systemic barriers limit representation and diversity in clinical trials, leading to greater disparities in healthcare. #xproject aims to overcome these obstacles and bridge the gaps in women’s health. Join us. #makethedifference
go.roche.com/xproject-inclusive-research -
Roche
@Roche
Retinal conditions affect millions of people globally, impacting the individual, their family as well as global health systems. See more on retinal diseases: futureofvision.global/home/the-reality-of-retinal-disease…
#transforminglives #patientsfirst -
Roche
@Roche
Is it possible to completely eliminate certain cancers? 🧐 When it comes to cervical cancer, we think the answer is yes. Learn more about how 👉 celebratelife.roche.com/explore/science/the-dream-became-… #roche125 #celebratescience #science
-
Roche
@Roche
We are pleased to see the commitment from the European Commission to extend its screening guidelines to include #lungcancer, an important first step in improving earlier diagnosis and a real opportunity to improve outcomes for people with lung cancer.
European Commission
@EU_Commission
🎗️ Cancer is a health priority for us.
We know: early detection saves lives and improves quality of life.
Under our #eucancerplan, we are taking a new approach on cancer detection – screening more and screening better.
Details: europa.eu/!6Ptk4V
#healthunion -
Roche
@Roche
"It feels right to end the day on my mom’s legacy. She made a huge impression on our community. The students she’s taught and the brides she’s designed flowers for. I think she’ll live on forever in the hearts of the people who love her". #worldalzheimersday
-
Roche
@Roche
"Style was always so important to my mom; she was always so fashionable, and it didn’t go unnoticed. Even now I’ll still take her to get her hair done once a week, so she feels like herself". #worldalzheimersday
-
Roche
@Roche
"Being Italian, food is a big part of our family life. My mom had a routine with food, and loved cooking with her twin sister, but some of these habits changed as her disease progressed, we’ve really had to navigate this change together". #worldalzheimersday
-
Roche
@Roche
"We always knew each other’s phone numbers by heart and now my mom can’t remember my number or hers. I try to spend part of every day with my mom. Sometimes she does not remember me at first, but once we start speaking, she usually knows who I am". #worldalzheimersday
-
Roche
@Roche
"When a loved one has Alzheimer’s sometimes it feels there is nothing you can do. But writing in her diary to help her remember things was something I felt made a difference, which was important to both me and her." #worldalzheimersday
-
Roche
@Roche
My mom was also an educator, teaching people of all ages. Whether they were 20-year-old kids who had dreams of becoming fashion designers, or moms who had never taken a college class, she inspired them all through her teaching and her kindness. #worldalzheimersday
-
Roche
@Roche
Hi everyone. I’m currently caring for my incredible mom, who is living with Alzheimer's disease. I’m taking over Roche’s Twitter this #worldalzheimersday to tell our story. First, I want to share her talent for flowers #twittertakeover
-
Roche
@Roche
Where are investments in #healthcare most needed to enable and accelerate patient access to health care innovations? #unga77
-
Roche
@Roche
We are on the cusp of a transformation in healthcare with the convergence of technology, data & science. When data become insights, systems learn. The care experience & health outcomes improve and patients benefit’- Deirdre Poretti, PHC Partner at Roche Ireland
#innovateforlife -
Roche
@Roche
It was a pleasure to be a partner in this event to celebrate the @GlobalFund achievements. We @Roche remain committed to the fight against HIV, TB and Malaria, in order to achieve the UN Sustainable Development Goals and the UNAIDS 95-95-95 targets.
Friends of the Global Fight
@theglobalfight
Friends’ board chair @JeffSturchio hosts a @BCIU panel with @GawandeUSAID @JaneRuth_Aceng @MoetiTshidi and Dr. Allan Pamba focusing on how the world can build up diagnostic capacity to fight the diseases of today as well as tomorrow
-
Roche
@Roche
The earlier #alzheimersdisease is detected and diagnosed, the better.
We believe early detection can help people living with Alzheimer’s retain their independence for longer.
Watch our #scienceinseconds video to find out more. #worldalzmonth -
Roche
@Roche
In a disease like #ipf, the impact on life can be tremendous, but it doesn't have to be. People living with IPF can and should fight for better outcomes and improve their daily lives. Check fightipf.com and discover many resources and advice from medical experts.
EU-PFF
@EU_IPFF
Despite #ipf being such a serious disease, there are still ways to enjoy life: "A chronic disease is an adjustment of life – not the end of it. There will have to be adjustments along the pathway." (Liam Galvin, EU-IPFF CEO)
#pfmonth #pulmonaryfibrosis #breathinglife #curepf -
Roche
@Roche
Missed to sign up to our next #linkedinlive? Diversity in clinical trials. Why inclusion of every eligible patient matters.” Michelle Rohrer, Global Head of Regulatory at Roche, invites you! Sign up here: www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
-
Roche
@Roche
We are delighted to announce that the European Commission has approved our novel bispecific antibody to treat people with nAMD and visual impairment due to DME, two leading causes of #visionloss. www.roche.com/404.html $RHHBY $ROG #rocheinnovation #eyehealth
-
Roche
@Roche
What do you think is the primary reason some women do not attend regular #cervicalcancer screenings? #valueofdiagnostics
Roche
@Roche
Advocating for regular #cervical screening can help save lives. #icymi watch our event on how we can help break down barriers to cervical cancer screening 👉go.roche.com/LiveEvent
#valueofdiagnostics -
Roche
@Roche
IEEPO started as an experience exchange with a small number of patient organizations coming together to discuss key topics. Today it’s 1 of the most influential patient communities, shaped by patient communities. It provides resources & tools to support patients to action change.
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
We’re supporting the Lymphoma Coalition’s “We Can’t Wait” campaign for #wlad2022, acknowledging the need for better awareness of the signs and symptoms of lymphoma to help with an earlier diagnosis, which can improve patient outcomes.
Lymphoma Coalition
@knowyournodes
World Lymphoma Awareness Day #wlad2022 is held on September 15. A day dedicated to raising awareness of #lymphoma an increasingly common form of cancer. Recognition, early diagnosis and treatment must be guaranteed equally accross the world. Learn more: lymphomacoalition.org/world-lymphoma-awareness-day/
-
Roche
@Roche
Our partners help us deepen our understanding of human biology with their unique expertise. We've joined forces with @RecursionPharma to combine our data and ML capabilities with their technology platform to produce maps of human cellular biology that will advance new medicines.
Recursion
@RecursionPharma
We're not alone in our mission to decode biology & radically improve lives.
Today we share a look behind the scenes at our #partnership with @roche and @genentech, building & navigating maps of biology in #neuroscience and an #oncology indication. Watch ⬇️This media couldn't be displayed. See it on the original post. -
Roche
@Roche
One hour to go! Today at 17:00 CEST follow a
a panel of experts through a lively discussion on how we can tackle barriers to access to cervical cancer screening methods. 👉 www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
#valueofdiagnostics -
Roche
@Roche
As #alzheimersdisease progresses, it impacts the parts of the brain responsible for memories, behaviour, problem-solving and daily activities.
Watch the third video in our #scienceinseconds series to find out more about the symptoms of Alzheimer’s.
#worldalzmonth -
Roche
@Roche
Today is World #sepsisawarenessday. Deaths from sepsis exceed the number of deaths from prostate cancer, breast cancer, and AIDS combined. Take the time to understand sepsis. 👉 www.sepsis.org/get-involved/sepsis-awareness-month/
#stopsepsis #rochefightssepsis -
Roche
@Roche
50 million lives have been saved by the
@globalfund partnership over the past 20
years. We are proud partners of @RED but
more must be done to reduce the death rate
due to HIV, TB and Malaria. Are you in?
#fightforwhatcounts
The Global Fund
@GlobalFund
Working together @GlobalFund partnership has saved 50 MILLION lives since 2002, proof that global commitment and community leadership can force the world’s deadliest infectious diseases into retreat. #fightforwhatcounts
www.theglobalfund.org/en/results/ -
Roche
@Roche
The treatments for hemophilia had always been given intravenously, and on-demand, until a team of scientists' idea at Chugai revolutionized the treatment landscape for good. 👉 celebratelife.roche.com/explore/science/haemophilia-treat…
#celebratelife #roche125 -
Roche
@Roche
You asked and they answered. Take a look back at the answers our panelists gave on the crucial questions around better access to healthcare. Watch the full event here 👉 www.youtube.com/watch?v=nf5OLEoTphw
#celebratelife #roche125 #rochelifetalks @muniba_mazari -
Roche
@Roche
Inequities in healthcare means cervical cancer disproportionately affects women in low- and middle-income countries, but new innovations help break down barriers to accessible care for many women. Read more at #xproject and help #makethedifference.
go.roche.com/notsofunfacts -
Roche
@Roche
Don’t miss today’s #doubletakeshow, a unique fashion show created by and featuring the spinal muscular atrophy (#sma) community! 👀👗 Sign up to watch the runway live!
Watch the show live: www.youtube.com/watch?v=yMXQws86GSo&t=0s -
Roche
@Roche
#dyk that almost 85% of cervical cancer cases occur in lower-resource countries? Join a live discussion on 14 September at 17:00 CEST to hear how we can bring access to cervical cancer screening for those who need it most. #valueofdiagnostics 👇
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Roche
@Roche
While #duchenne tends to affects males, approximately 1 in 50 million females can be diagnosed. We want to raise awareness of the women touched by #dmd, whether they are living with the condition, or are mothers, caregivers or advocacy leaders #wdad2022 www.worldduchenne.org/world-duchenne-awareness-day/
-
Roche
@Roche
We are excited about our new acquisition of @GoodTherapeutix to further catalyse our efforts to bring PD-1-regulated IL-2 to the broadest set of patients possible. PD1-targeted IL-2 therapeutics bear a huge potential to trigger our own immune system to kill cancer cells.
Good Therapeutics, Inc.
@GoodTherapeutix
We are excited to announce that @Roche has acquired Good Therapeutics’ innovative conditionally active PD-1-regulated-IL-2 program. The Good Therapeutics team has formed a new company, Bonum Therapeutics (@BonumTx). Learn more here: www.businesswire.com/news/home/20220907005310/en/Good-The…
-
Roche
@Roche
Researchers believe that #alzheimersdisease could be caused by changes to two proteins, impacting the brain. Watch to find out why researchers believe understanding these changes is crucial to stopping the disease in its tracks.
#scienceinseconds #worldalzmonth -
Roche
@Roche
Join us LIVE! #rochelifetalks
Reuters Plus
@ReutersPlus
Join @apldeap @ratnadevi2002 @muniba_mazari and Christoph Franz talking about challenges and opportunities of the healthcare system in Asia-Pacific #rochelifetalks
Paid for and created by @Roche x.com/i/broadcasts/1ypJdEZZawQxW -
Roche
@Roche
We are LIVE! Join the conversation! 👉 www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
#celebratelife #roche125" -
Roche
@Roche
Just one more day to go! Hear what our panelists have to say about the importance of accessible healthcare. Join the conversation on the 5th of September! 👉 www.facebook.com/event_invite/20ijSzsKB/
#celebratelife #roche125 -
Roche
@Roche
Worldwide, 1 person dies from #sepsis every 2.8 seconds. For those 11 million people each year, rapid recognition and treatment are crucial to their survival. This month, take time to understand sepsis and learn more: diagnostics.roche.com/global/en/products/product-category… #sam2022 #rochefightssepsis
-
Roche
@Roche
Roche Chairman Christoph Franz on our new office tower in Basel: “Building 2 is one of the most sustainable and energy efficient office buildings worldwide.”
-
Roche
@Roche
Today our Chairman Christoph Franz opens our new office tower in Basel: “Building 2 offers an ideal environment for collaboration, creativity and innovation - all of which are key for Roche’s continued success.”
-
Roche
@Roche
Let’s face it - #cervical screening can be stressful. Collecting your own sample privately can help remove obstacles that cause people to delay this type of gynecologic appointment. Find out how #hpvtesting is evolving. 👇 #valueofdiagnostics
www.roche.com/stories/cervical-cancer-self-sampling -
Roche reposted
Apl.de.Ap
@apldeap
I am a one in a million case. I had to come to the US to seek treatment for my vision impairment. This should never be the case as we need to find solutions for people back in the Philippines. Join me September 5th as I'll be talking to @ratnadevi2002 and @muniba_mazari.
Roche
@Roche
✨ 📺👇Meet our fantastic panel. Only 8 days left until our exciting #rochelifetalk. Be part of conversation. 👇 #celebratelife #roche125
www.facebook.com/event_invite/20ijSzsKB/ -
Roche reposted
Muniba Mazari
@muniba_mazari
“Healthcare access is not a luxury, it’s a necessity. It’s not a favour, it’s a basic human right. After all everyone has the right to live a dignified & healthy life.” - Muniba Mazari
@Roche Thank you for the opportunity!
#rochelifetalk #munibamazari #healthcareaccess
Reuters Plus
@ReutersPlus
Hear @Apldeap, @Muniba_Mazari and @RatnaDevi2002 perspectives and experiences about making access to healthcare more widely available in Asia and the rest of the world. Read more at www.reuters.com/article/sponsored/where-you-live-should-n…. #rochelifetalks
In partnership with @Roche -
Roche
@Roche
#alzheimersdisease isn’t a normal part of ageing - it’s a medical condition.
Watch the first video in our #scienceinseconds series to find out more about the known risk factors for Alzheimer’s.
#worldalzmonth #knowalzheimers -
Roche
@Roche
We are proud to join @EU_IPFF in raising awareness of Pulmonary Fibrosis and its challenges to the daily lives of patients and their families. Together we’ll bring the fight to #pf.
#pfmonth #breathinglife #transforminglives
EU-PFF
@EU_IPFF
Pulmonary Fibrosis Awareness Month #pfmonth takes place every year in September and wants to draw attention to #pulmonaryfibrosis, its challenges & the changes it brings about in daily life, and the burden it places on patients and their loved ones. #breathinglife #curepf
-
Roche
@Roche
Today marks the start of World Alzheimer’s Month.
Throughout September we are going to be sharing the science and stories behind an Alzheimer’s disease diagnosis.
Tell us: what are you most interested to learn about this month?
#worldalzmonth -
Roche
@Roche
Don't miss our #linkedinlive session: Diversity in clinical trials: Why including every eligible patient matters. Join us with Michelle Rohrer, Global Head of Regulatory will be joined by expert panelists to reflect on this topic. Register here www.linkedin.com/uas/login?session_redirect=https%3A%2F%2…
-
Roche
@Roche
#smaawarenessmonth is about to end and what a month it’s been! We couldn’t be more thankful to all those involved within the #spinalmuscularatrophy community for your ongoing support, partnerships, and
collaborations. -
Roche
@Roche
At Roche, we don’t let numbers define us. Just like Sweety, we recognize how important differences are in bringing forward innovative ideas. #celebratelife #diversityandinclusion #ageism #equity #generations
-
Roche
@Roche
What if we could use the power of vaccines to treat cancer? It’s not as crazy as it sounds. Learn about how we’re working to make personalized cancer vaccines a reality. #roche125 👉🔬💡 celebratelife.roche.com/explore/science/cancer-vaccines/
-
Roche
@Roche
✨ 📺👇Meet our fantastic panel. Only 8 days left until our exciting #rochelifetalk. Be part of conversation. 👇 #celebratelife #roche125
www.facebook.com/event_invite/20ijSzsKB/ -
Roche
@Roche
Johannes’ passion for new technology knows no bounds. A retired Roche automation engineer, he’s experienced firsthand the importance of diversity in innovation. Because at Roche, age does not define us.
#celebratelife #diversityandinclusion #ageism #equity #generations -
Roche
@Roche
We are delighted that @Thomas_ades premieres his Roche-commissioned piece Air at @LucerneFestival tomorrow. Congratulations to Beat Furrer who was awarded the next Roche Commissions.
Lucerne Festival
@LucerneFestival
"@Roche Commissions" 2022 and 2024
The world premiere of "Air" by @Thomas_ades will take place tomorrow with Anne-Sophie Mutter and the LFCO.
The 12th edition of "Roche Commissions" will go to Swiss-born Austrian composer Beat Furrer.
Read more at www.lucernefestival.ch/en/news/187 📰 -
Roche
@Roche
Women are more likely to die from type 1 diabetes secondary complications than men, a disparity caused partly by a lack of research in women’s diabetes. Follow #xproject and help us bridge these gaps in women’s health to #makethedifference. go.roche.com/notsofunfacts
-
Roche
@Roche
For Roche Chairman Christoph Franz, the answer to the world’s growing healthcare challenges lies in stronger global partnerships. Join our upcoming LifeTalks and continue the conversation. #rochelifetalks 👉www.reuters.com/article/sponsored/providing-global-access…
-
Roche
@Roche
Any cancer diagnosis can be emotionally traumatic, but it’s particularly difficult to hear “we don’t know where your cancer is coming from.” Marlene, a Roche biochemist, says we’re shedding light on the unknown in cancer. #fightforcup #esmo21 www.roche.com/stories/voices
-
Roche
@Roche
Attending AACR21 and interested in the latest advancements in cancer immunotherapy? Don’t miss Pablo Umaña’s presentation as part of the New Drugs on the Horizon Symposia www.abstractsonline.com/pp8/
-
Roche
@Roche
At this year's fully virtual @BioConvention, Alex Szidon, Head of Partnering of Genentech’s R&D organization talked about why developing strong partnerships are essential to develop breakthrough innovation. Watch his full presentation now.
-
Roche
@Roche
Join us at this year’s @BioConvention to learn more from Alex Szidon, Head of Partnering of Genentech’s R&D organization on why Roche & Genentech are your partners of choice. Watch his presentation now. #biodigital
-
Roche
@Roche
How can we better inform those affected by #breastcancer about the different forms of the disease? Start by learning more and hearing the unique experiences of three women living with breast cancer. #myshadeofpink www.roche.com/research_and_development/what_we_are_workin…
This media couldn't be displayed. See it on the original post. -
Roche
@Roche
Find out why we believe that Boston has become one of the most fertile environments for #biotech innovation in the world. #bio2018 www.roche.com/stories/boston-a-boon-for-biotech

















































































































































































































































































































































































































































































































































































